The Role of Cited Family Proteins in the Developing Kidney by Boyle, Scott Clifford
THE ROLE OF CITED FAMILY PROTEINS IN THE 
DEVELOPING KIDNEY 
 
By  
Scott Clifford Boyle  
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY 
in 
Cell and Developmental Biology 
August, 2007 
Nashville, Tennessee 
 
Approved: 15 May 2007 
Mark de Caestecker  
Chris Wright, Chair 
Scott Baldwin 
Ray Harris  
Guoqiang Gu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To Abatha,  
Thank You. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ii
ACKNOWLEDGEMENTS  
 
 The work presented in this dissertation was preformed in the Department 
of Cell and Developmental Biology, Vanderbilt University School of Medicine 
between 2002 and 2007.  I would like to thank the Department for their continued 
support during this time and for providing such an exciting and collaborative 
environment in which to work.  I would also like to thank the Program in 
Developmental Biology for their support and strong commitment to the training 
of developmental biologists.  My participation with this enthusiastic group has 
greatly enriched my scholastic progress during my time at Vanderbilt.   
 I would like to begin by thanking my mentor, Mark de Caestecker.   Your 
passion for science is unmatched and continues to motivate me, even when I think 
you are off the deep end.  You have been an instrumental part of my scientific 
development, and the lessons I have learned during my time in your lab will go 
with me throughout my career.  I feel privileged to have trained under you, but am 
more proud to call you my friend.  I look forward to continuing our never ending 
discussion about kidney development and hope for much productive collaboration 
in the future.   
 There are many people in my life without whom I would not have reached 
this point; I should start at the beginning.   
 I would like to sincerely thank my father and mother, Kevin and Mary 
Boyle.  Your unwavering support and commitment has brought me to this point, 
and for that I am forever indebted to you.  Education was always the priority 
 iii
when we were growing up and two mantras have stuck with me; ‘Work hard’ and 
‘Do your best.’  I believe I have done both over the course of my education, and I 
hope I have made you proud.   As a proper scientist, I should not neglect to thank 
you for the DNA, it has served me well.   
 I would also like to thank my sister Amanda.  I’m not sure we could be 
more different, yet I feel proud to call you one of my best friends.  You have 
always been so unconditionally supportive, and I look forward to the relationship 
our families will share in the future.   
 To my amazing wife, Abatha.  It’s no secret to anyone who knows us that 
there is little chance I would have gotten to this point without you.  My life has 
been different since the day we met, and I’ll never know how to thank you for 
your support and sacrifice over the past six years.  Our entire marriage has been 
this PhD; I hope that I have made you proud.  I thank you for all of the nights that 
I came home completely defeated by science, and you reminded me; “This is why 
they call it research”…and… “If it was supposed to be easy, everyone would do 
it”.  I don’t say it enough, Thank You.   
  I would also thank you for your collaboration on the best developmental 
biology project I have done over the past six years, Nate.  He has been such an 
amazing part of this experience, and I can’t wait for what the future holds.  Thank 
you, Nate for being the ultimate antidote to bad days, and reminding me why what 
I do is important.   
 iv
 To Wayne, Debbie, Emily, and Hamil; Thank you for making me part of 
your family, and showing me all of the time that the most interesting science 
happens outside of the lab.   
 I would like to thank all of the friends I have made at Vanderbilt during 
my time here, especially Ryan, Audra and Quinn Pooley.  This was an amazing 
shared experience for our families and our lives are forever linked.  To David 
‘Felix’ Frank, who has been a mentor and a friend.  I have learned so much from 
you, and will be forever grateful for all of the pints and all of the science.  To 
Drew Misfeldt; building the BACs was a purely collaborative endeavor that I 
could not have accomplished alone, thank you.  To Melissa Langworthy, I have 
enjoyed our shared interest in the kidney and our friendship.  And to Josh 
Rosenberg, fellow music snob.  Thanks for being the guy I never have to talk 
science with.                
 I would especially like to thank my committee; Chris Wright, Scott 
Baldwin, Ray Harris, and Guoqiang Gu.  Our meetings have always energized my 
efforts and provided me countless avenues for thought.  I thank you for your 
support and appreciate your commitment to my scientific development.   
 I would like to thank all members of the de Caestecker lab past and 
present, including (but not limited to) David Frank, Genbin Shi, Lynda Anderson, 
Becky Breeding, Bo Lovvorn, Shaun Opperman, Jen Westrup, Monique Brink, 
and Amir Abathi.    
Of course, this work would not have been possible without the 
contributions of our collaborators, both in terms of shared interest and reagents.  I 
 v
would especially like to thank Alan Perantoni, Toshi Shioda, Sallie Dunwoodie, 
Duncan Sparrow, Shoumo Bhattacharya and Doug Mortlock.  I would also like to 
extend my thanks to the Scott Baldwin lab.  You have been my one stop shop for 
all things developmental biology.  I appreciate your collaborative spirit and 
unending willingness to help.  I would especially like to thank Kevin Tompkins 
for pronuclear injections to create the Cited1-CreERT2 mice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi
TABLE OF CONTENTS 
 
Page 
DEDICATION.................................................................................................................... ii 
ACKNOWLEDGMENTS ................................................................................................. iii 
LIST OF TABLES............................................................................................................. ix 
LIST OF FIGURES .............................................................................................................x 
LIST OF ABREVIATIONS ............................................................................................ xiii 
Chapter                                                                                                                           
I.  INTRODUCTION...........................................................................................................1 
Overview .................................................................................................................1 
Kidney development in the mouse ..........................................................................3 
Molecular programs which regulate kidney development in the mouse...............10 
The CITED family of transcriptional co-factors ...................................................28 
 
II.  CITED FAMILY PROTEINS ARE DYNAMICALLY EXPRESSED IN               
THE DEVELOPING KIDNEY BUT ARE NOT REQUIRED FOR      
NEPHROGENESIS .....................................................................................................37 
 
            Introduction............................................................................................................37 
Experimental procedures .......................................................................................38 
Results ...................................................................................................................42 
Discussion .............................................................................................................63 
 
III. CITED1 REGULATES CELL ADHESION TO THE EXTRA-CELLULAR 
MATRIX IN MCF7 CELLS........................................................................................71 
 
Introduction ...........................................................................................................71 
Experimental procedures .......................................................................................73 
Results and Discussion..........................................................................................77 
Conclusion.............................................................................................................86 
 
IV. GENERATION OF CITED1-CREERT2 MICE REVEALS PATTERNS OF 
CAP METANEPHRIC MESENCHYME CELL FATE .............................................88 
       
            Introduction............................................................................................................88 
 vii
 viii
Experimental procedures ......................................................................................91 
Results and Discussion..........................................................................................94 
Conclusion...........................................................................................................127 
 
V.  DISCUSSION AND FUTURE DIRECTIONS .........................................................129 
Cited1 in the developing kidney..........................................................................129 
Cited2 and Cited4 in the developing and adult kidney........................................132 
Regulation of cell-ECM interactions by Cited1 ..................................................135 
Cited1-CreERT2 mice and patterns of cap mesenchyme differentiation............137  
Concluding remarks.............................................................................................141 
 
BIBLIOGRAPHY............................................................................................................142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF TABLES 
 
Table                                                                                                                              Page 
1.   Genes required for early metanephric development ..............................................13, 14 
2.   Quantification of embryonic and adult kidney structures in wild type and 
Cited family mutant mice.............................................................................................58 
 
3.   Distribution of expected and observed survival for genotypes of interest during     
generation of Cited1/2 compound mutant mice……………………………………...58  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix
LIST OF FIGURES 
 
Figure                         Page 
1.   Schematic of early kidney development in mice ...........................................................4 
2.   Schematic of MM patterning, epithelial differentiation and nephron patterning 
in the developing kidney................................................................................................8 
 
3.  Expression of notable molecules required for proper kidney development .................16 
4.   Effects of Cited1 overexpression in cultured kidneys and activity on BMP and 
Wnt signaling pathways...............................................................................................33 
 
5.  Cited1LacZ expression in the developing kidney ...........................................................44 
6.   Expression of Cited1 protein in the developing kidney...............................................46 
7.   Cited1 is downregulated as cap mesenchyme cells differentiate and has an 
expression pattern distinct from Pax2 and WT1..........................................................48 
 
8.   Deletion of Cited1 does not disrupt nephrogenesis .....................................................50 
9.   Expression of Cited2 in the developing and adult kidney ...........................................52 
10. Method for analysis of UB branching and epithelial differentiation in cultured 
kidneys .........................................................................................................................55 
 
11. Deletion of Cited2 does not perturb UB branching or induction of new   
nephronic epithelia.......................................................................................................56 
 
12. Compound deletion of Cited1 and Cited2 does not perturb UB branching or   
induction of new nephronic epithelia...........................................................................59 
 
13. Cited4 expression in the developing and adult kidney ................................................62 
14. Deletion of Cited4 does not disrupt UB branching or overall nephrogenic 
process..........................................................................................................................64 
 
15. Context dependent subcellular localization of Cited1 .................................................67 
16. Knockdown of Cited1 in MCF7 cells ..........................................................................78 
17. Effects of Cited1 knockdown on MCF7 cell migration and adhesion.........................81 
 x
18. Actin organization in attaching MCF7GapdhK/D and MCF7Cited1K/D cells .......................83 
19. Adhesion defects in MCF7Cited1K/D cells are not due to changes in candidate 
integrin expression or altered phosphorylation of FAK. .............................................85 
 
20. Selection and targeting of BAC for generation of Cited1-CreERT2 transgenic 
mice..............................................................................................................................96 
 
21. Introduction and modification of BAC into EL250 bacteria .......................................98 
22. Characterization of potential Cited1-CreERT2 founder lines .....................................103 
23. CreERT2 and Cited1 expression in offspring from two potential founder lines.........105 
24. Schematic of Cited1-CreERT2 transgene copy number transmission from 
founder (F0) through generation four (F4)..................................................................107 
 
25. eGFP expression in Cited1-CreERT2 transgenic kidneys ..........................................110 
26. Lineage tracing of cap metanephric mesenchyme labeled at E13 .............................112 
27.  Cap mesenchyme lineage in specialized nephronic epithelia ...................................115 
28. The cap mesenchyme does not give rise to renal endothelial cells or contribute 
to the collecting duct..................................................................................................118 
 
29. Progressive fate of the cap mesenchyme cell during the course of kidney 
development...............................................................................................................120 
 
30. The cap metanephric mesenchyme is a self-renewing progenitor cell 
population ..................................................................................................................123 
 
31. Kinetics of Cre subcellular localization following tamoxifen injection in 
Cited1-CreERT2 kidneys ............................................................................................126  
 
 
 
 
 
 
 
 
 
 
 
 xi
LIST OF ABREVIATIONS 
 
BAC  bacterial artificial chromosome 
BP  basepair 
CAM  chloramphenicol 
CM  condensed mesenchyme 
E__  embryonic day 
ECM  extra cellular matrix 
eGFP  enhanced green fluorescent protein 
FAK  focal adhesion kinase 
Gdnf  glial derived neurotropic factor 
IM  intermediate mesoderm 
IRES  internal ribosomal entry site 
KB  kilobase   
μL  microliter 
μM  micromolar 
MM  metanephric mesenchyme 
NB  newborn 
ND  nephric duct 
nM  nanomolar 
ORF   open reading frame 
O/N  overnight 
P___  postnatal day  
PFGE  pulse field gel electrophoresis 
PTA  pre-tubular aggregate 
RBC  red blood cell 
RT  room temperature 
RV  renal vesicle 
SID  smad-interacting domain 
SM  stromal mesenchyme 
TGFβ  transforming growth factor beta.   
UB  ureteric bud 
UGS   urogenital system 
UTR  untranslated region 
WT  wildtype 
 
 
 xii
CHAPTER I 
 
INTRODUCTION 
 
Overview  
Development of the mammalian kidney is based upon the establishment of a 
reciprocal tissue interaction between the ureteric bud (UB) and the metanephric 
mesenchyme (MM) (for review see (Dressler, 2006).  The UB is an epithelial tube that 
emerges from the nephric duct (ND) around embryonic day 10.5 (E10.5) in the mouse, 
invading the MM, an overlying population of renal progenitor cells in the nephrogenic 
cord.  Invasion of the UB leads to patterning of the MM into the condensed mesenchyme, 
which surrounds UB tips and branch points, and stromal mesenchyme, a more loosely 
associated group of cells that border the condensed mesenchyme.  Cross talk between the 
UB, condensed mesenchyme and stroma drives conversion of progenitor cells into 
nephronic epithelia and provides for the continued growth and iterative branching of the 
UB.  Much work over the past decade has demonstrated that these events are controlled 
and integrated at the transcriptional level (for review see(Boyle and de Caestecker, 2006; 
Schmidt-Ott et al., 2006; Yu et al., 2004).    
 In a screen to identify factors which regulate this process, the transcriptional 
cofactor Cited1 was found to be expressed in the MM and downregulated as these cells 
undergo epithelial differentiation in response to UB-derived inductive signals (Plisov et 
al., 2000).  Cited1 (Cbp-P300 Interacting Transactivators with E/D rich tails) is the 
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founding member of a family of non-DNA binding transcriptional cofactors that includes 
Cited2 and Cited4 in mammals and an additional member, Cited3, in lower vertebrates.   
 The primary focus of my research has been to investigate the expression and 
function of Cited family proteins during kidney development in the mouse.  An additional 
aim has been to exploit the Cited1 expression domain to fate map renal progenitor cells 
and create a broadly applicable tool to study gene function in the MM.  Chapter one will 
describe kidney development in the mouse and highlight key regulatory networks 
responsible for early specification and inductive events.  It will go on to discuss the 
identification of Cited1 as a gene regulated during MM differentiation and highlight what 
is known about this family of transcriptional co-factors.  Focusing initially on Cited1, 
chapter two will include detailed expression profiles of Cited proteins in the developing 
kidney and present data that demonstrate that these genes are not required for 
nephrogenesis.  I have also used in vitro methods to address the function of Cited1, and 
chapter three will demonstrate a role in regulation of cell adhesion and migration.  
Chapter four will describe the creation of a Cited1-CreERT2 transgenic animal, which I 
have used to trace progenitor cell lineage in the developing kidney and uncover patterns 
of cell fate.  This mouse is also a powerful tool for conditional gene deletion in the MM. 
In chapter five I will conclude by discussing how my work is relevant to the field of 
kidney development and highlight potential future experiments that will allow for better 
understanding of this process.       
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Kidney development in the mouse 
The kidney has received extensive attention from developmental biologists since 
the nature of its reciprocal tissue interactions was first described more than fifty years ago 
(Grobstein, 1953; Vize et al., 2002).  There are three kidney structures which arise during 
mammalian development (Fig. 1A).   The pronephros and mesonephros develop first and 
are transient structures in mammals that serve as excretory organs during in utero 
development.  Subsequently the permanent kidney, or metanephros, is formed in the 
posterior aspect of the intermediate mesoderm (IM), in between the lateral and somitic 
mesoderm (Fig. 1B). 
The first structural evidence of nephrogenesis in the mouse arises around 
embryonic day 8 (E8), with the formation of two parallel epithelial tubes known as the 
nephric ducts (ND).  This process occurs through mesenchyme to epithelial 
differentiation, and is dependent on factors secreted by the overlying surface ectoderm 
and somites (Obara-Ishihara et al., 1999).  Once formed, the ducts extend towards the 
posterior, or caudal, pole of the embryo, forming the core component of the developing 
urogenital system (UGS).  The period between E8 and E9.5 is marked by formation of 
the pronephros and mesonephros, relying on many of the same induction mechanisms 
and genetic programs required for metanephric development (Vize et al., 1997).   
The earliest changes associated with development of the metanephric kidney 
begin around E10.5, as cells within the posterior region of the IM aggregate to form a 
structure known as the metanephric mesenchyme (MM).  This group of cells is believed 
to contain precursors for epithelial, stromal and vascular elements of the adult kidney, but 
has not been definitively fate mapped.  Formation of the MM is associated with the  
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Figure 1.  Schematic of early kidney development in mice. A. Sagital view 
of E10 mouse embryo, just prior to UB outgrowth  B. Cross section of E8 
mouse embryo demonstrating relative position of the IM, site of the 
presumptive nephrogenic field.  C. Outgrowth, invasion and early branching 
of the UB.  The MM is patterned into stromal and condensed elements in 
response to UB invasion. 
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expression of a distinct profile of transcription factors within the posterior portion of the 
IM.  This culminates in the expression of the secreted growth factor Gdnf which activates 
its receptors Ret/Gfrα1 to induce an outgrowth from the ND known as the ureteric bud 
(UB). This epithelial structure invades the overlying MM, establishing the reciprocal 
tissue interaction that characterizes kidney development (Fig. 1C; (Cacalano et al., 1998; 
Moore et al., 1996; Pichel et al., 1996; Sainio et al., 1997; Schuchardt et al., 1996).  All 
subsequent developmental events within the metanephric kidney are dependent on the 
coordinated cellular response resulting from invasion of the UB into the MM.     
 Initially, the UB secretes factors which rescue the MM from apoptosis and induce 
patterning of the MM. In response, MM cells condense around the UB tip to form a 
structure known as the cap metanephric mesenchyme.  These cells represent a subset of 
the MM and are believed to give rise to most of the specialized epithelial cells within the 
mature nephron. This population is distinguishable from the surrounding, loosely packed 
stromal mesenchyme, which plays an important role in support and patterning of 
differentiating cap cells (Fig. 1C, 2A; (Jena et al., 1997; Levinson and Mendelsohn, 
2003).  MM patterning is dependent on UB invasion, but the specific signaling pathways 
that promote the segregation of cap and stromal mesenchyme are not known.  It is, in fact, 
unclear whether establishment of the stromal compartment reflects migration of 
exogenous cells into the metanephric region, segregation and expansion of precursor cells 
within the MM, or both.     
Factors secreted by the UB initiate a program of stepwise differentiation in cap 
mesenchyme cells.  This start of this process is characterized by the formation of small 
clusters of cells contiguous with the ventral aspect of the cap structure, called pre-tubular 
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Figure 2.  Schematic of MM patterning, epithelial differentiation and nephron 
patterning in the developing kidney. A.  Characteristic branched UB and 
associated patterned MM.  Early epithelial differentiation is marked by the 
formation of the PTA and the RV.  B. Formation of the comma- and S-shaped 
bodies.  Fusion with the UB and endothelial invasion are key events during this 
stage.  C. Elongation and patterning of collecting system and distal nephron 
segments.   Continued formation of new nephrons in the outer, nephrogenic zone. 
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aggregates (PTA; Fig. 2A; (Sariola, 2002).  These cells undergo a burst of proliferation 
before they begin to express junctional and basement membrane markers, forming early 
polarized epithelial structures known as renal vesicles (RV).  Having established UB 
invasion, MM derived signals then provide for continued growth and symmetrical 
branching of the UB (Fig 1C, 2C).  This in turn promotes patterning and differentiation of 
the overlying cap mesenchyme within the outer, nephrogenic zone of the developing 
kidney.  At the same time, PTA structures undergo further polarization as they form RVs 
lined with columnar epithelium.  These vesicles undergo a series of invaginations and 
become first comma- and then S-shaped bodies, fusing with the extending UB to form a 
continuous lumen (Fig. 2B).   
These events mark the initiation of a program of proximal and distal patterning 
that gives rise to distinct tubular segments and glomeruli, and are associated with 
recruitment of stromal and vascular cell components.  Distally patterned elements 
elongate into the medulla and also connect the nephron to the UB-derived collecting 
system (Fig. 2C).  UB branching and nephron differentiation occur throughout embryonic 
development, but 85% of the branching events are complete by E16.5. Detailed 
morphometric analysis indicates that there is a second, temporally distinct phase of 
nephrogenesis after E16.5 associated with a marked increase in tubular growth and 
patterning of nephron segments (Fig. 2C; (Cebrian et al., 2004).  This results in expansion 
of the renal cortex and patterning of medullary regions of the adult kidney.  
The iterative nature of these events suggest that there are likely to be populations 
of multi-potent stem cells within the cap mesenchyme and UB tips that provide a 
continuous supply of progenitor cells as nephrogenesis progresses.  These cells have yet 
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to be positively identified. Furthermore, it is in the comma-shaped body (possibly as 
early as the RV), that the differential expression of markers which delineate specific 
segments in the adult nephron is first observed (Cheng et al., 2007; Kobayashi et al., 
2005).  This is important because it suggests that cell fate may already be determined at 
this early stage.  This also raises questions about the commitment stage of cap 
mesenchyme cells.  Is an individual cell within the cap predetermined to become say, a 
glomerular podocyte, or is fate determined at a later stage by positional cues in primitive 
nephrons? 
 
Molecular programs which regulate kidney development in the mouse 
 Much of our understanding of the process described above comes from global 
gene deletion studies in the mouse.  Work over the past decade has demonstrated the 
requirement of several secreted growth factors, transcription factors and cell surface 
receptors for proper development of the kidney (Table 1, Fig. 3).  This part of the thesis 
will discuss, at the molecular level, some of the programs which are crucial in vivo for 
specification and induction during the early phases of metanephric development.  The 
purpose of this section is not to discuss every protein that has been implicated in kidney 
development, but rather to cover aspects of this process which form the foundation of my 
work.   This section will not address the molecular mechanisms within the UB that 
regulate branching morphogenesis.  For additional information on this subject the reader 
is referred to (Costantini and Shakya, 2006; Dressler, 2006; Shakya et al., 2005).  
Specifically, I aim to highlight: 
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1) The transcriptional control of kidney development.  As the principal focus of my 
research has been a family of transcriptional co-factors, I will demonstrate how 
early events during nephrogenesis are regulated by complex networks of 
evolutionarily conserved transcription factors and co-factors.  Important cell 
surface receptors and secreted molecules will be covered as well.   
2)  The concept of functional redundancy between members of a gene family.  As an 
example of this paradigm, I will discuss the role of Pax2 and Pax8 in specification 
of the ND.  A primary aim of my work has been to determine if Cited family 
proteins can compensate for one another during kidney development.   
3)  The difficulties in studying broader aspects of kidney development inherent in 
global gene deletion strategies.  In addition to its usefulness for lineage tracing, 
our generation of a Cited1-CreERT2 transgenic mouse is a direct response to this 
problem and will allow for temporal control of gene deletion in the cap 
mesenchyme, circumventing the requirement for a given factor in early events.        
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Table 1.  Genes required for early metanephric development. All factors have 
been shown to play a critical role during kidney development in vivo.  SGF –
secreted growth factor, TF- transcription factor, CSR – cell surface receptor.  
Competence (MM comp?) refers to the ability of isolated MM to differentiate 
when exposed to an inductive signal, such as isolated UB or spinal cord.  
12
 
Gene 
 
Type 
 
Early Expression 
 
Kidney Phenotype 
 
Molecular Phenotype 
 
 
MM 
Comp? 
 
Notes 
 
 
BMP4 
 
 
SF 
E10.5 mesenchyme 
surrounding ND 
E11.5 mesenchyme 
surround stalk of 
UB 
 
 
 
Hypoplaisa, cystic 
(Hets/Hypomorph) 
 
Pax2, c-Ret present but with 
reduced expression domains 
Gdnf normal, WNT11 reduced 
in explant system 
 
 
N/A  
Global deletion results in lethality ar 
gastrulation.  Promotes UB outgrowth and 
stromal MM expansion in vitro.    
 
BMP7 
 
SF 
E11.5 UB, MM 
E12 PTA 
 
 
Bilateral displasia, 
hydroureter 
Wnt4, Pax2, Pax8, WT1 all 
initially expressed, but 
progressively lost 
 
 
Yes 
 
Required for survival of MM 
 
Eya1 
 
TF 
 
E8.5 IM 
E10.5 ND, U-MM 
E11.0 Cap MM  
 
Agenesis, MM not 
specified from IM 
 
Six1, Six2, Pax2, 
Gdnf lost 
 
MM not 
formed 
Tx co-factor.  Only mutant identified in 
which MM does not form. No MM may be 
the cause of GDNF loss, but there is also 
evidence for direct regulation (ref) 
 
 
FGF8 
 
 
SGF 
 
E11.5 Ventral MM 
(Presumptive PTA) 
E12 PTA 
 
 
Severe hypoplasia, 
arrest at RV stage 
Cap MM apoptosis 
WT1, Pax2, NMyc, Gata3 
initially normal but lost as MM 
depleted 
Wnt4 and Lim1 reduced in 
PTA 
No 
(can be 
rescued 
w/FGF8 
bead) 
Conditional deletion w/ T-cre (mesodermal 
lineages) to avoid lethal gastrulation defect.  
Survival signal specific for cap, stroma not 
affected. 
 
FoxC1/2 
 
TF 
 
E9.5 MN 
E10.U-MM 
E11.0 Stromal MM 
 
Duplex kidney 
 
Eya1, Gdnf expanded 
 
Yes 
Define GDNF expression boundaries, 
specifying site of UB outgrowth. 
GDNF SGF  
E11 MM  
Agenesis, no UB 
outgrowth 
N/A Yes Can promote UB outgrowth in vitro 
Gfrα1  CSR  
E10 ND 
Agenesis, no UB 
outgrowth 
N/A ? Ret co-receptor 
 
Hoxa/c/d11 
 
TF 
 
E10.5 U-MM 
E11.0 Stromal MM 
 
Agenesis (triple 
knockout) 
 
Gdnf, Six2 absent 
Eya1 normal 
 
? 
 
No phenotype in individual mutants 
 
LIM1  
 
TF 
 
E12 PTA 
 
Hypoplasia, non 
functional 
 
Brn1, Dll1  lost in RV 
 
 
 
Yes 
 
Conditional deletion w/ Rar2β Cre to avoid 
early IM defects.  Mosaic analysis shows 
Lim -/- cells cannot contribute to … 
 
Gene 
 
 
Type 
 
Expression 
 
Kidney Phenotype 
 
Molecular Phenotype 
MM 
Comp? 
 
Notes 
 
Pax2 
 
TF 
 
E8.5 IM, ND 
E10.5 U-MM 
E11.0 UB- MM 
 
Agenesis, failure of 
UB outgrowth 
 
Gdnf absent 
 
No 
Pax8 can rescue early defect in ND 
formation, but not in MM.   
 
 
 
Pbx1 
 
TF 
 
 
E10.5 U-MM 
E11.0 MM 
 
Expansion of cap 
MM, UB branching 
reduced, Hypoplasia 
 
Pax2, Wt1 expanded 
Brn1, Pod1 (stroma) 
normal 
 
Reduced 
 
 
 
Ret 
 
CSR 
E9 ND  
E11-UB; strongest in tips 
Agenesis.  ND is 
formed, limited 
capacity for UB 
outgrowth 
 
N/A 
 
N/A 
Mosaic studies show Ret -/- cells 
cannot contribute to UB tips (Ref)   
 
Rarα/β2 
 
CSR 
 
E11.5 Stromal MM 
 
Hypoplasia, agenesis 
 
Pax2, Wt1, Gdnf, Bmp7 
normal 
 
Yes 
 
  
 
Sall1 
 
TF 
 
E9.5 MN, ND 
E10.5 U-MM 
E11.0 condensed MM 
 
Agenesis (variable), 
failure of UB 
outgrowth 
 
Pax2, Wt1, Eya1, Gndf 
reduced 
 
Yes 
Molecular phenotype likely results from 
hypoplastic MM and not direct 
regulation.   
 
 
Six1 
 
TF 
 
E10.5 U-MM 
E11.0 condensed MM 
 
Agenesis, Failure of 
UB outgrowth 
 
Pax2, Six2, Sall1 absent 
Eya1, Gdnf, Wt1 normal 
 
No 
UB outgrowth fails despite detectable 
Gdnf.   
 
 
Six2 
 
TF 
E10.5U-MM 
E11 condensed MM 
Severe hypopalsia, 
few differentiated 
epithelial structures 
WNT4↑ in ectopic PTA  
Yes 
Maintains MM; ectopic PTA form on 
dorsal side of UB in K/O 
Wnt4   
SGF 
E12 PTA  Agenesis, PTA forms 
but does not progress 
Fgf8, Pax8 initially  
expressed in PTA 
No UB invades and MM condenses. Can 
induce differentiation of isolated MM 
in vitro 
Wnt9b   SGF E10.5 ND, E11 ventral aspect 
of UB branches 
Agenesis/ severe 
hypoplasia 
FGF8, Pax8, Wnt4 absent Yes UB invades and MM condenses, but 
PTA does not form 
 
Wt1 
 
TF 
 
E10.5 U-MM  
 
Agenesis 
 
Six2, Gndf, Pax2 normal 
 
 
No 
Pax2 mRNA is present, protein is not.   
 
Figure 3.  Expression of notable factors required for proper kidney 
development . A. E10.5, Expression of key factors in the UB and uninduced 
MM (UMM) prior to UB outgrowth and invasion.  B.  E12.5.  Expression of 
key factors in UB, condensed mesenchyme (CM), stromal mesenchyme (SM), 
and pre-tubular aggregate (PTA).  Location of gene name within given 
structure does not indicate a specific location of expression.  
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Regulation of nephric duct formation by Lim1, Pax2 and Pax8 
Lim1, also known as Lhx1, is a homeodomain DNA binding transcription factor 
that is initially detected in the visceral endoderm during gastrulation, and is differentially 
expressed in multiple tissues during development (Karavanov et al., 1998).  In the 
developing UGS, expression is initiated in the lateral plate and IM at E8.5.  As the pro- 
and mesonephros are formed within the IM, expression is lost in the lateral plate and 
becomes restricted to the mesonephric tubules and the ND.  Pax2 and Pax8 are two 
closely related members of a family of paired-box DNA binding transcription factors that 
have largely overlapping expression domains in the developing kidney (Bouchard et al., 
2002).  Much like Lim1, Pax2 is expressed early in the IM that gives rise to the renal 
anlage, and both Pax2 and Pax8 are expressed in the ND as it extends posteriorly towards 
the cloaca (Bouchard et al., 2002; Dressler et al., 1990).   
Global deletion of Lim1 is usually embryonic lethal due to a defect in formation 
of the placenta (Shawlot and Behringer, 1995).  The few mice that do survive until birth 
lack all IM derived structures, including the kidneys (Tsang et al., 2000).  More detailed 
analysis of these mutant mice indicated that Pax2 is initially expressed at low levels in 
the anterior portion of the intermediate mesoderm, but fails to extend posteriorly into the 
nephrogenic region.  Analysis of Hoxb6, which marks a wider area of mesoderm 
including the IM, ND and lateral plate, reveals markedly reduced expression in Lim1 
mutant mice.  This decrease is seen only in the IM, the presumptive site of ND and 
pro/mesonephros formation, while expression of Hoxb6 is unaffected in the lateral plate. 
Taken together, these data suggest that Lim1 is specifically required for the 
differentiation of early nephrogenic structures within the IM.   
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Like Lim1, deletion of Pax2 results in loss of the mesonephric tubules and the 
metanephric kidney (Bouchard et al., 2002; Torres et al., 1995).  In fact, marked kidney 
defects are observed in Pax2 heterozygotes, indicating that gene dosage is an important 
component of its function (Torres et al., 1995).  Unlike Lim1 mutants however, the ND 
forms in Pax2 mutants, but fails to extend caudally to the level of metanephric 
development (Torres et al., 1995).  Based on its wider expression in the IM, it is 
surprising that the ND forms at all in the absence of Pax2.  The fact that Pax8 is also 
expressed in the ND raises the possibility that it can functionally compensate for loss of 
Pax2 in this structure.   Consistent with this, deletion of both Pax2 and Pax8 results in a 
complete failure of ND formation (Bouchard et al., 2002).  Interestingly, deletion of Pax8 
alone does not disrupt formation of the meso- or metanephric kidney (Mansouri et al., 
1998), suggesting that loss of function may be completely compensated for by Pax2 in 
the anterior intermediate mesoderm.  The relationship between Lim1 and the Pax gene 
products during these early stages of kidney development is less clear.  Most likely, the 
absence of Pax2 in the posterior intermediate mesoderm of Lim1 mutants reflects the 
failure of these differentiated structures to form, and not direct regulation of Pax2 
expression by Lim1 (Tsang et al., 2000).  However, our understanding of these early 
events in kidney development is limited to these descriptive studies, so that the precise 
relationship between these genes remains unclear.  
 
The Eya1/Pax2/Six1 transcriptional circuit 
Aside from formation and extension of the ND, establishment of the interaction 
between the MM and the UB is initially dependent on specification of the MM from the 
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IM and its subsequent ability to stimulate emergence of the UB.  Eya1, Pax2, and Six1 
are part of a network of transcriptional regulators that have been well characterized in 
drosophila eye development (Brodbeck and Englert, 2004; Treisman, 1999).  
Remarkably, this network has been evolutionarily conserved and plays a critical role in 
both specification of the MM and stimulation of UB outgrowth.   
 
Specification of the metanephric mesenchyme   
While the precise architecture of transcriptional networks in the MM is poorly 
understood, it is clear that Eya1 plays an essential role in regulating early events during 
nephrogenesis (Sajithlal et al., 2005; Xu et al., 1999; Xu et al., 2002).   Eya1 is one of 
four mammalian orthologues of Drosophila eyes absent (eya), and is expressed in the IM 
from E8.5 and more specifically in the ND and the uninduced MM at E10.5.  As in the 
Drosophila eye, the expression domain of Eya1 in the MM overlaps with that of other 
members of the Eya/Six/Pax network.  Mammalian so orthologues Six1 and Six2 are 
expressed in the MM prior to UB invasion, as are the toy and ey orthologues Pax2 and 
Pax8 (Bouchard et al., 2002; Xu et al., 2003).  The dac orthologue, Dach1 is expressed in 
early nephronic epithelia of the developing kidney (Ayres et al., 2001), however, there 
are no published data relating to its functional role in renal development.  Initial studies 
indicated that Eya1 null mutant mice died at birth with renal agenesis (Xu et al., 1999; 
Xu et al., 2002).  More detailed analysis has demonstrated that these mice have a normal 
ND and mesonephros, but fail to form the distinct MM aggregate at E10.5 in the posterior 
region of the IM  (Sajithlal et al., 2005).  To date, this is the only mutant identified that 
results in the failure of the MM to be specified from the IM. A caveat to these studies is 
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that Eya1 is a non-DNA binding transcriptional co-factor that must interact with other 
DNA binding factors in order to activate or repress transcription.  This suggests that Eya1 
expression alone is unlikely to be sufficient to specify the MM.  Given the biochemical 
data demonstrating functional and physical interactions between Eya and Six family 
proteins (Li et al., 2003; Ohto et al., 1999), it is possible that Eya1 acts by modifying the 
transcriptional activity of Six family members in the MM.  Indeed, Six1 is co-expressed 
with Eya1 in the MM and Six1 null mice also fail to form kidneys (Xu et al., 2003), 
suggesting that specification may require the assembly of Six1/Eya1 complexes in the 
presumptive MM, however this has yet to be definitively shown.   
 
Stimulation of UB outgrowth from the nephric duct   
Outgrowth of the UB and its subsequent invasion of the MM is an essential 
induction step in development of the metanephros proper.  This event is dependent both 
on a signal secreted by the MM (Gdnf) and the expression of its receptors (Ret/Gfrα1) in 
the ND.   Deletion of any of these components limits the ability of the UB to emerge and 
results in renal agenesis (Cacalano et al., 1998; Sanchez et al., 1996; Schuchardt et al., 
1996).  It follows that deletion of genes in the uninduced MM which compromise its 
ability to produce Gdnf, or genes in the UB which effect expression of Ret or Gfrα1 also 
have this phenotype.  Indeed, in most of the mouse mutants which specifically lack 
kidneys, alterations in this program account for the primary defect (Table 1).  Because of 
this, establishing the transcriptional network upstream of Gdnf in the MM has received 
considerable attention from the field in recent years.  In vivo and in vitro studies clearly 
demonstrate a role for Pax2 in the regulation of Gdnf expression in the MM (Brophy et 
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al., 2001).  In addition to the ND, Pax2 is expressed in the MM prior to UB invasion 
(Dressler et al., 1990).  The MM forms properly in Pax2 null mice, however, it fails to 
express Gdnf (Brophy et al., 2001).  Pax2 binds and activates defined elements within the 
Gdnf promoter suggesting that it directly regulates Gdnf expression (Brophy et al., 2001), 
but other components of this network up- and downstream of Pax2 are less clear.  Based 
on their overlapping expression patterns and common phenotype, speculation has focused 
on other members of the Eya/Pax/Six network.   
Initial characterization of the Eya1 knockout mouse at E11.5 revealed that 
expression of Pax2, Six1, and Gdnf were lost in the area of the MM (Xu et al., 2002) 
while other studies have shown that Eya1 expression is independent of Pax2 (Xu et al., 
2003).  Together these data make it tempting to speculate that Eya1 acts upstream of 
Pax2 and Six1 in a transcriptional circuit driving Gdnf expression in the MM.  However 
as discussed above, the MM never forms in Eya1 null mice, making it unclear whether 
these effects are due to the direct regulation of this pathway by Eya1 or simply a 
consequence of losing the MM.  Furthermore, Gdnf expression is maintained in the MM 
of Six1 null mice despite the failure of the UB to emerge from the ND (Xu et al., 2003).  
It is unclear whether this is simply an effect of reduced Gdnf dosage that is not reflected 
by in situ hybridization, or if another, parallel pathway is required for UB outgrowth.  For 
example, deletion of the Hoxa11/Hoxc11/Hoxd11 gene cluster also results in loss of Gdnf 
expression in the MM and the subsequent failure of UB outgrowth, despite normal 
expression of Pax2 (Wellik et al., 2002).   It is unclear if these genes regulate Gdnf 
expression through an independent, non-redundant pathway, or if they are part of a 
common transcriptional network downstream of Pax2.  Studies in the developing 
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Drosophila eye may provide insight into these mechanisms.  Overexpression of the Hox 
orthologue antennapedia in the eye inhibits transcriptional responses mediated by the Pax 
orthologue, eyeless by competitive inhibition of DNA binding (Plaza et al., 2001).  If a 
similar mechanism is operative in the mammalian kidney, these findings would suggest 
that the Hox11 paralogues could play a direct role in modifying the transcriptional 
activity of Pax2.  This would account for the loss of Gdnf despite maintenance of Pax2 
expression in Hoxa11/Hoxc11/Hoxd11 compound mutant mice.  
 
Making nephrons: progenitor cell maintenance and differentiation   
The formation of early epithelial structures from the MM involves a host of 
coordinated cellular events which not only give rise to primitive nephrons, but also 
replenish the MM for future rounds of differentiation.  These processes are likely not 
mutually exclusive, though the relationship between the two is unclear.  Furthermore, in 
many of the mouse mutants in which kidney development fails, the UB never invades the 
MM, complicating the study of subsequent events.  This is important as a number of key 
early factors are expressed at later stages of nephrogenesis, and presumably play a role in 
these contexts.  A handful of recent studies, however, have shed light on factors which 
are important for maintenance and differentiation of progenitor cells in the developing 
kidney.  
 
Differentiation of the cap mesenchyme  
The precise signals and downstream effectors which are necessary (and/or 
sufficient) for epithelialization of the MM have been elusive. An especially contentious 
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point has been the nature of the signal (thought to be UB derived) which initiates 
differentiation of cap mesenchyme cells. Several studies using explanted kidneys from 
rats have identified factors which have this property in vitro (Barasch et al., 1999; 
Perantoni et al., 1991; Plisov et al., 2001; Rogers et al., 1993), though until recently none 
has been shown to be required in vivo in mice.  Numerous pieces of evidence have 
implicated the Wnt signaling pathway as being important for MM differentiation.  Many 
Wnt ligands are expressed in the developing kidney, but the studies of Wnt4 and Wnt9b 
are the most remarkable, demonstrating a clear role for these genes in initiation and 
maintenance of MM epithelialization.   Wnt4 is expressed in the PTA, and its deletion 
results in renal agenesis (Stark et al., 1994).  Examination of early stages of kidney 
development in these mice demonstrates that while the UB invades the MM properly and 
even undergoes a few rounds of branching, no MM derived epithelial structures are 
present, including RVs.  Furthermore, Wnt4 expressing cells can induce epithelialization 
of MM explants in vitro (Kispert et al., 1998).  Together these data suggest that Wnt4 is 
both necessary and sufficient for MM differentiation, and is required during the early 
stages of this process.  However, because Wnt4 is expressed in the PTA, but not earlier in 
condensed mesenchyme, it is unlikely to be the signal that initiates conversion of cap 
mesenchyme cells into epithelia.  Recent studies have shown that UB derived Wnt9b is 
required in vivo for initiation of cap mesenchyme differentiation and formation of the 
PTA (Carroll et al., 2005).  Wnt9b is expressed in the branched ends of the UB, most 
prominently on the ventral aspect and, like Wnt4, deletion results in renal agenesis.  
Formation of the PTA is normally associated with the expression of a distinct group of 
makers on the ventral side the cap mesenchyme including Fgf8, Pax8 and Wnt4 (Fig 3B).  
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In the Wnt9b mutant, the UB invades the MM and branches, cap cells condense around 
the bud tips, but expression of this panel of makers is lost.  This indicates the PTA fails to 
form in the absence of Wnt9b.   Interestingly, Pax8 and Fgf8 are initially expressed in 
Wnt4 null mice, suggesting initial differentiation of cap cells to form the PTA occurs in 
these animals but does not progress to the RV stage.  Together these data evoke a model 
in which the sequential activity of Wnt9b and Wnt4 are respectively required to first 
initiate and then maintain epithelial differentiation of nephron precursors.     
 
Maintenance of the cap mesenchyme  
 Progenitor cells within the cap mesenchyme must be continually repopulated to 
be available for induction by new UB branch tips and the formation of successive 
generations of nephrons.  In general our understanding of this process is limited.  One 
could imagine two possible models for this phenomenon.  The cap mesenchyme could be 
repopulated by exogenous cells migrating in and condensing around UB tips, thereby 
filling the void left by differentiating cells.  Alternatively, there could be a program 
within the cap mesenchyme whose job it is to oppose signals from the UB promoting 
differentiation, thereby allowing some cap cells to persist and repopulate this niche.   The 
later is generally thought to be true, and fate mapping results I will present in chapter four 
strongly support a model by which cap cells are capable of self renewal.  Furthermore, a 
recent report has demonstrated that the transcription factor Six2 is required for 
maintinence and renewal of cells within the condensed mesenchyme (Self et al., 2006).   
 Six2 is expressed in the MM prior to emergence of the UB and is restricted to the 
condensed mesenchyme in response to invasion.  Outgrowth of the UB and condensation 
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of the MM are not affected in Six2 null mice, but by e16.5 these mice have markedly 
smaller kidneys than wild type littermates.  This is associated with disorganized epithelial 
structures and loss of condensed mesenchyme around UB tips; stromal cells are not 
affected.  One possible explanation for this phenotype is that Six2 holds condensed MM 
cells in an undifferentiated state, and that in its absence all progenitor cells are exhausted 
in initial rounds of differentiation.  Indeed, Six2 null mice develop ectopic RVs on the 
dorsal side of the UB, as opposed to the usual location just ventral to the UB tip (Fig. 3C 
(Self et al., 2006).  This phenotype is associated with the progressive loss of MM specific 
markers (such as Eya1) and inappropriate expression of RV markers (such as Wnt4 and 
Sfrp2).  It also appears that abnormal apoptosis of MM cells after UB invasion 
contributes to the loss of progenitor cells in Six2 null mice; however given the presence 
of ectopic RVs it is likely that the primary function of Six2 is to oppose differentiation 
rather than promote survival.  Importantly, these phenotypes can be rescued in kidney 
explants by expressing ectopic Six2 (Self et al., 2006).   
The signals (and their origin) which act upstream of Six2 to maintain progenitor 
cells in an undifferentiated state are unknown, though several reports have demonstrated 
that Bmp7 acts as a crucial survival signal for the condensed mesenchyme (Dudley et al., 
1999; Dudley et al., 1995; Luo et al., 1995).  In the absence of Bmp7, early MM genes 
such as Pax2 and WT1 are initially expressed and Wnt4 is present in the area of the PTA.  
These markers are progressively lost, and like the Six2 null mice, this seems to be 
associated, at least in part, with apoptosis of the condensed MM.  Bmp7 null mice have 
not been analyzed for the presence of ectopic RVs, making it unclear if Bmp7 acts strictly 
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as a survival factor or if it also lies up- or downstream of Six2 in a pathway that promotes 
persistence of the condensed mesenchyme.    
 
Genetic manipulation of kidney development: traditional limitations and new 
approaches 
 
Additional in vivo genetic studies of cap mesenchyme differentiation and 
maintenance have been limited as many of the factors that are expressed in the MM and 
primitive epithelial structures are also required for early specification and/or inductive 
events (Table 1).  Historically, this problem has been addressed in vitro by studying the 
ability of isolated MM structures from E11.5 mutant mouse embryos to undergo 
differentiation when exposed to potent inductive signals from spinal cord or wild type 
UB isolates.   This approach has enabled us to identify several so called ‘competence’ 
factors that are required for this process (Table 1), but it is unclear from these studies 
whether the apparent requirement for these factors in vitro actually reflects their 
functional role in the context of intact metanephroi.  A good example of this problem 
comes from the analysis of Wt1 null mutant mice, in which there is complete loss of MM 
structures by E12.5 with no evidence of differentiation (Kreidberg et al., 1993).  Tissue 
recombination experiments demonstrate that wild type spinal cord and UB structures are 
unable to rescue the Wt1 null MM phenotype in vitro (Donovan et al., 1999; Kreidberg et 
al., 1993), suggesting that Wt1 could be a competence factor for MM differentiation.  
Loss of Wt1 is also associated with a marked increase in apoptosis of the uninduced MM 
over the 24 hour period following its formation (Kreidberg et al., 1993).  The 
inappropriate death of MM cells in Wt1 null mice makes it impossible for tissue 
recombination experiments to determine whether the primary function of Wt1 is to act as 
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a survival/maintenance factor for the MM or if it has an additional role in regulating 
differentiation.   
Many of these issues can now be circumvented using Cre/LoxP technology to 
delete genes in a spatially and temporally controlled manner.  Creating a tool useful for 
such studies has been one of the primary aims of my work, and will be presented in 
chapter 4.    A recent example of this approach in the developing kidney is the deletion of 
Lim1 exclusively in MM-derived structures using Rarb2-Cre and Lim1LoxP conditional 
mice, thus bypassing the early requirement for Lim1 in the IM (Kobayashi et al., 2005).  
These studies demonstrated that in the absence of Lim1, the PTA and RV form normally, 
but fail to undergo further differentiation or express nephron segment specific markers, 
Dll1 or Brn1.  These findings indicate that Lim1 is not required for initial differentiation 
of the cap mesenchyme, but is essential for subsequent patterning of the RV into tubular 
structures of the nephron.  An alternative approach to study later function of genes 
essential for early patterning is to study cell behavior in vivo using mosaic mice generated 
by introducing mutant ES cells with lineage specific markers into wild type blastocysts.  
This approach has recently been used to evaluate the functional role of Ret signaling in 
regulating UB branching morphogenesis (Shakya et al., 2005).  By limiting the dosage of 
Ret-/- cells, the authors were able to track and study mutant cell function while preserving 
early renal development programs.  Together, conditional deletion and mosaic studies 
should enable us to determine the role of a given factor in later events and the functional 
relationship between genetic pathways which regulate kidney development.   
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The CITED family of transcriptional co-factors 
In a screen to discover novel factors which regulate differentiation of the MM, the 
transcriptional co-factor Cited1 was identified (Plisov et al., 2000).  In this study it was 
shown that Cited1 is expressed in MM explants at an early stage and is downregulated as 
cells express markers of differentiation in response to UB conditioned medium.   
Cited1 (Cbp-P300 Interacting Transactivators with E/D rich tails) is the founding 
member of a family of non-DNA binding transcriptional cofactors which includes Cited2 
and Cited4 in mammals and an additional member, Cited3, in lower vertebrates.  These 
factors share a highly conserved C-terminal transactivation domain (CR2) and bind core 
elements of the transcriptional machinery such as P300, in addition to a variety of 
transcription factors (Braganca et al., 2003; Braganca et al., 2002; Plisov et al., 2005; 
Shioda et al., 1997; Yahata et al., 2001; Yahata et al., 2002).  Cited1 also contains a 
Smad interacting domain (SID) not present in other family members, required for activity 
downstream of TGFβ signals (Plisov et al., 2005; Yahata et al., 2000).  Germline deletion 
studies implicate Cited1 and Cited2 in a variety of developmental processes.  Few studies 
have addressed the expression or biological function of Cited4.    
 During embryogenesis, Cited1 is required for proper trophoblast function, as null 
animals exhibit placental insufficiency causing growth defects late in gestation and death 
at birth (Rodriguez et al., 2004).  In these mice, deletion of Cited1 causes a 
disorganization of both maternal and embryonic blood vessels within the placenta.  This 
effect is dependent on genetic background; Cited1C57Bl/6 null mice suffer from placental 
insufficiency while Cited1Svj129 null animals do not.  In addition, Cited1 is required for 
maturation of the mammary gland during puberty (Howlin et al., 2006).  Female 
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Cited1SVJ129 null mice display abnormal branching and organization of the ductal tree at 
the onset of puberty.  This process is known to be regulated by TGFβ and estrogen 
signaling, both of which can be activated by Cited1 (Plisov et al., 2005; Yahata et al., 
2000; Yahata et al., 2001).    In the absence of Cited1 there is an impairment of ductal 
outgrowth, consistent with reduced estrogen signaling.  There are also defects in duct 
patterning, which is regulated by TGFβ (Howlin et al., 2006).  This process is interesting 
because it represents a developmental program at work later in life and shares common 
themes with kidney development, such as progenitor cell differentiation and migration as 
well as  branching morphogenesis .   
In addition to its role during development, Cited1 is differentially expressed in 
many malignant cell types.  The initial discovery of Cited1 was in a mouse melanoma 
cell line and it has subsequently been shown to be associated with melanogenesis  (Nair 
et al., 2001; Shioda et al., 1996) and malignancies of the skin (Sedghizadeh et al., 2005).  
Cited1 has also been linked to malignancies of the thyroid, where it has emerged as a 
possible diagnostic indicator of tumor stage and prognosis (Fluge et al., 2006; Fryknas et 
al., 2006; Huang et al., 2001; Prasad et al., 2004).   
Most interestingly, our lab has recently shown that Cited1 is highly expressed in 
Wilms’ tumor, a relatively common pediatric malignancy of renal origin (Lovvorn et al, 
2007, in review).  Wilms’ tumors are thought to arise from pockets of MM that fail to 
undergo epithelial differentiation called nephrogenic rests, resulting in retention of these 
cells in the tumor.  It is in these poorly differentiated cells that Cited1 is expressed, 
primarily in the nucleus.  These data are intriguing when considering normal and 
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abnormal development of the kidney, and will be discussed further at the end of Chapter 
two.   
  Cited2 is the best characterized member of this gene family.  Its role as a 
competitive inhibitor of HIF1α has been extensively described at the biochemical level, 
and seems to be its primary mode of action in the developmental setting (Bhattacharya et 
al., 1999; Bhattacharya and Ratcliffe, 2003; Freedman et al., 2003).  Deletion of Cited2 
results in embryonic lethality between E13.5 and E17.5, likely due to defects in the heart 
and/or placental vasculature (Bamforth et al., 2001; Weninger et al., 2005; Withington et 
al., 2006; Yin et al., 2002).  In the developing heart, deletion of Cited2 results in 
widespread abnormalities including septal defects in the atria and ventricles, a doubling 
of the right ventricular outlet and persistent truncus arteriosus (Bamforth et al., 2001).  
These defects are likely manifestations of abnormal left/right body axis formation in 
Cited2 null mice (Bamforth et al., 2004; Weninger et al., 2005).     
In addition to cardiac and placental defects, Cited2 null mice lack adrenal glands, 
display abnormal cranial ganglia, and have exencephaly resulting from failed closure of 
the neural tube (Bamforth et al., 2001; Weninger et al., 2005; Yin et al., 2002).  This 
neural tube defect is interesting because it can be rescued by administering folic acid to 
pregnant females (Barbera et al., 2002), suggesting that Cited2 is involved in the genetic 
pathways which underlie spina bifida in humans.   
 
Cited1 in the developing kidney 
Though Cited1 has been identified as being regulated during the early stages of 
kidney development, its function in this setting is unknown.  We have previously 
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published a report investigating the role of Cited1 in the developing kidney (Plisov et al., 
2005).  These studies were primarily carried out in vitro and provide the foundation for 
studying the expression and function of Cited1 in vivo, which has been the principal 
focus of my research.  As background, I will provide a summary and brief discussion of 
this paper, as well as a composite of key data (Fig. 4).    
As it had been previously shown that differentiation of the MM was associated 
with downregulation of Cited1 (Plisov et al., 2000) we asked what effect Cited1 
overexpression would have on kidney development.  For these studies cultured kidney 
rudiments were transduced with TAT-Cited1, a fusion protein whose ‘TAT’ domain 
mediates cellular uptake.  When Cited1 is overexpressed in this manner, cultured kidneys 
display fewer nephronic epithelia and reduced UB branching, while TAT alone has no 
effect (Fig 4A-C).  Furthermore, in kidneys treated with TAT-Cited1 there appears to be 
an expansion in the size of the MM.  These effects are dose dependent as higher 
concentrations of TAT-Cited1 exacerbate the phenotype (compare Fig. 4B to 4C).    
Condensation of the MM and nephron induction is dependent on UB branching,  making 
it unclear which is responsible for the primary defects observed here.  If the role of 
Cited1 in the MM was to directly influence the differentiation state of cap cells, 
overexpression may block epithelial conversion, resulting in fewer primitive nephrons 
and an expansion of the cap structure.  This failure of MM differentiation would then 
perturb the normal tissue interactions required by the UB, thereby reducing total 
branching.  Alternatively, Cited1 could modulate expression of a MM derived factor 
which regulates UB branching.  In this case the reduced UB branching observed in TAT-
Cited1 kidneys would result in fewer new nephrons being induced.   One way to address  
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Figure 4. Effects of Cited1 overexpression in cultured kidneys and activity 
on BMP and WNT signaling pathways (adapted from Plisov et al., 2005.) A-
F. TAT-Cited1 overexpression in intact metanephric rudiments (A-C) or 
isolated MM (D-F). A. Control explant incubated with TAT alone.  B,C. 
Explants incubated with increasing concentrations of TAT-Cited1. White 
arrows – new nephronic epithelia, Red arrow – expanded MM region with 
absence of nephronic epithelia.  D. Control isolated MM incubated with 
survival factor Fgf2.  E. Control isolated MM induced to form tubules by 
addition of UB conditioned medium; Arrow- epithelial tubules F. Isolated 
MM treated with TAT-Cited1 and UB inductive medium. G. Effect of Cited1 
on BMP7 mediated transcriptional responses.  Left panel - schematic of 
constructs (inset – respective expression levels by western blot).  Right panel 
– activity of Cited1 and deletion mutants on Smad responsive luciferase
reporter. H. Effect of Cited1 on Wnt mediated transcriptional responses.  I.
Schematic model of bi-functional hypothesis of Cited1 function in the MM.  
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this question is to use isolated MM cultures, which can be induced to form tubule 
structures with UB conditioned medium (Fig. 4E), thereby removing the influence of UB 
branching.  When TAT-Cited1 is added to isolated MM and cultured in inductive 
medium, tubular epithelial structures do not form (Fig 4F).  Together, these data imply 
that the primary role of Cited1 is to regulate the differentiation state of MM cells.   
We then asked what biochemical properties of Cited1 could shed light on its role 
in the MM.  It has been previously reported that Cited1 can mediate transcriptional 
responses downstream of TGFβ superfamily ligands  (Shioda et al., 1998; Yahata et al., 
2000).  Reporter assays using the SBE-Lux reporter (Smad responsive) in NmuMg cells 
demonstrate that Cited1 can activate transcriptional responses downstream of BMP7 (Fig 
4G).  This effect is dependent on both the CR2 and SID domains of Cited1.  Cited1 also 
has the capacity to repress Lef/TCF4 mediated Wnt transcriptional responses as measured 
by activity of the OT-Lux reporter (Fig 4H).  This inhibition is dose dependent and 
requires the CR2 but not the SID domain (Fig. 4H, (Plisov et al., 2005).      
This result is intriguing because both of these pathways have been shown to play 
a crucial role in regulation of early events in the MM.   Both Bmp4 and Bmp7 are 
required for nephrogenesis (Table 1; (Dudley et al., 1999; Dudley et al., 1995; Dunn et al., 
1997; Luo et al., 1995; Miyazaki et al., 2000).  As discussed above, BMP7 is necessary 
for recruitment and survival of the condensed mesenchyme, while BMP4 has been 
implicated in UB outgrowth and expansion of the stromal MM and can substitute for the 
loss of BMP7 in the developing kidney (Oxburgh et al., 2005).  Wnt9b and Wnt4 are 
required for the initiation and maintenance of epithelial differentiation, respectively, of 
cap mesenchyme cells (Carroll et al., 2005; Kispert et al., 1998; Stark et al., 1994).  
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Together these data suggest a number of possible models for Cited1 activity in the 
condensed mesenchyme (Fig. 4I).  If the primary function of Cited1 in the MM is to 
mediate BMP-dependent responses, it could act downstream of BMP7 or BMP4 to 
promote maintenance or proliferation of cap cells.  Alternatively, Cited1 could act as a 
Wnt antagonist in the MM, repressing target genes until they are needed for formation of 
the PTA. Downregulation of Cited1 during cap mesenchyme transition would alleviate 
this repression in those cells forming the PTA and allow expression of genes needed for 
epithelialization.  This could explain the reduced nephron induction when Cited1 is 
overexpressed in cultured kidneys.  Furthermore, Cited1 could function in both of these 
pathways simultaneously, making it tempting to speculate that Cited1 acts a ‘gatekeeper’ 
in the MM.  In this model, downregulation of Cited1 would be a transcriptional switch 
that allowed for conversion of cap cells into the PTA, shutting off BMP responses 
important for maintenance, and de-repressing WNT targets needed for differentiation.  
This hypothesis is reminiscent of what has been observed in the maturing mammary 
gland, where it appears that Cited1 acts downstream of TGFβ and estrogen signaling 
simultaneously (Howlin et al., 2006).             
 While this study certainly suggests a role for Cited1 in kidney development, it 
primarily uses in vitro methods to addresses what Cited1 can do in this context.  This is 
different from understanding what Cited1 actually does in the MM.  This question forms 
the basis of the work presented here.  The primary aim of my project has been evaluate 
the expression and function of Cited1 in vivo, using knockout mice to evaluate 
nephrogenesis in its absence.  This work has also led to the characterization of Cited2 and 
Cited4 during kidney development, as well as the creation of Cited1/2 double mutant 
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animals.  This work is detailed in Chapter 2.  I have also used in vitro methods to 
evaluate the function of Cited1, and demonstrated a role in regulation of cell migration 
and adhesion, presented in Chapter 3.  In Chapter 4 I will describe how we exploited the 
Cited1 expression domain to lineage trace cap mesenchyme cells and create a unique tool 
for conditional gene deletion in these cells.   To conclude I will discuss the impact of my 
work on the field of kidney development and suggest future directions for the research 
presented here.   
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CHAPTER II 
 
CITED FAMILY PROTEINS ARE DYNAMICALLY EXPRESSED IN THE 
DEVELOPING KIDNEY BUT ARE NOT REQUIRED FOR NEPHROGENESIS 
 
 
Introduction 
To address the function of Cited family proteins in the developing kidney, we 
mapped their expression during nephrogenesis and evaluated the consequences of 
germline deletion during this process.  My studies initially focused on Cited1, as this was 
the factor identified in the original differential display screen (Plisov et al., 2000).  We 
show that Cited1 expression is initiated in the MM after invasion of the UB and becomes 
restricted to the cap mesenchyme, those condensed cells directly opposed to UB tips.  As 
cap cells begin to differentiate, Cited1 is downregulated in the PTA, absent in the RV, 
and is not expressed in any differentiated elements of the kidney.  Despite its dynamic 
expression pattern, we show that deletion of Cited1 does not disrupt nephrogenesis.  We 
hypothesized that this was due to functional redundancy through other members of this 
gene family.  Indeed, Cited2 and Cited4 are also expressed in the developing kidney.  
Cited2 expression overlaps with Cited1 in the condensed MM, but persists in 
differentiating epithelial structures, including glomeruli.  Conversely, Cited4 is expressed 
only in the UB, most prominently in the tips.  Because of their overlapping expression 
patterns we focused on Cited2 as a candidate for redundancy.   
 To test our hypothesis, we evaluated kidney development in Cited2 null and 
Cited1/2 compound mutant animals.  Deletion of Cited2 had a modest effect on UB 
branching and the formation of new epithelia, but did not alter the overall growth of 
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cultured kidneys.  Investigating kidney development is Cited1/2 compound mutants was 
problematic due to a hastening of embryonic lethality observed in Cited2 null mice.  In 
those embryos that did survive until the onset of kidney development we did not observe 
major perturbations in UB branching or differentiation of new epithelia.  
 Expression and function of Cited4 in the developing kidney has not been 
previously addressed.  We show that Cited4 is expressed early in the ND and later in the 
tips of the UB, directly opposed to Cited1 expressing cells.  Like Cited1 and Cited2, 
deletion of Cited4 does not disrupt nephrogenesis.  Based on these studies we conclude 
that Cited family proteins are differentially expressed in the developing kidney, but are 
not required for nephrogenesis.   
 
Experimental Procedures 
 
Animals 
Generation  of Cited1LacZ (Howlin et al., 2006; Sado et al., 2000), Cited2+/- 
(Bamforth et al., 2001) and Cited2LacZ  (Barbera et al., 2002) mice has been previously 
described. Cited4LacZ mice were made in the Toshi Shioda lab (MGH) in a manner similar 
to the Cited1LacZ animals, with a β-galactosidase/neomycin cassette replacing the open 
reading frame (Figure 13A).  Mice were genotyped using the following primers.   
Cited1WT    
5’ - TTA CTT GCA GAC CAA CAG GC  
3’- TGC TTC TTT GAC CCA TTT CC 
 
Cited1LacZ  
5’ - TTA CTT GCA GAC CAA CAG GC  
3’ - GCG AGT AAC AAC CCG TCG GAT TCT CCG TGG 
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Cited2WT  
5’ - AAA GGC GCT AAG GAT AGA CAC  
3’ - ATA CTG AGG TCC CTG GCA C  
 
Cited2Neo  
5’ - CTA CCC GGT AGA ATT GAC CTG  
3’ - TGC TGT AAG ACC TTC TTG GC  
 
Cited2LacZ
5’  - TGG CGT TAC CCA ACT TAA TCG CCT TGC AGC 
3’ -  GCG AGT AAC AAC CCG TCG GAT TCT CCG TGG 
 
Cited4WT  
5’- TCA AGG TAG TGT CTA GCC CA 
3’- TGA GCT GTT GAG AGC CAC CA   
 
Cited4LacZ  
F- CCG GGT GAG ACA GTG AAC GAA TCC GAT TTA TTC 
R- GCG AGT AAC AAC CCG TCG GAT TCT CCG TGG 
 
Cited1LacZ mice are maintained on the 129/SvJ background.  Cited2+/- and Cited4LacZ mice 
are maintained on the C57Bl/6 background, and Cited2+/LacZ mice on a mixed background. 
Timed pregnancies were counted with the morning of vaginal plug appearance as day 0.5.  
 
β-Gal staining 
Whole embryos or kidneys were isolated in cold PBS and fixed in 0.4% 
glutaraldehyde in PBS with 2mM MgCl2 and 5mM EGTA.  Fixation times were 
determined empirically and varied from 1 to 4 hours at 4°C according to age.  For whole 
mount staining, embryos were equilibrated in β-Gal wash (0.1M Phosphate buffer pH 7.3 
containing 2mM MgCl2, 5mM EGTA, 0.02%NP40, 0.01% NaDeoxycholate) and stained 
O/N at 37°C in β-Gal wash containing 1mg/ml X-Gal and 5mM K+ ferro- and 
ferricyanate.  Embryos were cleared for photography using a glycerol gradient in PBS.  
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For frozen sections, fixed tissues were cryoprotected in 30% sucrose in PBS o/n, 
sectioned at 10 μm, and stained as described above.  Sections were counterstained with 
eosin, dehydrated and mounted.   
 
Immunohistochemistry 
Paraffin embedded tissues were sectioned at 6μm, and subject to antigen retrieval 
using buffered citrate.  After allowing slides to cool, tissue was blocked in 10% goat 
serum in PBS for 1 hour.  Sections were incubated with 1° antibodies o/n at 4°c.  After 
washing 3 x 5 minutes in PBS, sections were incubated with 2° antibodies for 1 hour at 
r/t, washed again 3 x 5 minutes in PBS and mounted with Vectashield containing dapi 
(Vector Labs).    
 
Antibodies 
Polyclonal rabbit anti-Cited1 (NeoMarkers #RB-9219) was used at 1:250.  
Monoclonal mouse anti-ECadherin (BD biosciences cat # 610181) was used at 1:300. 
Polyclonal rabbit anti-calbindin D28k (Calbiochem, #PC253L) was used at 1:1000. 
Polyclonal rabbit anti-Pax2 (Zymed/Invitrogen #71-6000) and WT1 (Santa cruz #SC192) 
were used at 1:100. HRP conjugated Tetragonolobus purpureas lectin, (Sigma L5759) 
was used at 0.3mg/ml.  Conjugated secondary antibodies included horse anti-mouse 
fluoresine (Vector Labs #FI-2000) and goat anti-rabbit Rhodamine X (Jackson 
Immunoresearch #111-295-144) both used at 1:250.     
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Organ culture isolation and staining 
Metanephric rudiments were isolated at E12, and grown for 5 days on clear 0.4 
μm transwell filters (corning costar #3460) in DMEM containing 10% FBS.  For 
immunostaining, filters were fixed in cold methanol for 10 minutes, and incubated with 
primary antibodies diluted in 5% goat serum in PBST (PBS + 0.1% Tween 20) o/n at 4°C.  
Filters were washed extensively the next day at room temperature in PBST, with the final 
wash extending o/n at 4°c.  Cultures were incubated with 2° antibodies for 1 hour at R/T, 
washed 3 times 1 hour in PBST and mounted with vectashield (Vector labs).   
 
Glomerular Counts  
Glomeruli were counted as previously described (Godley et al., 1996).  Briefly, 
individual kidneys were isolated from adult mice ( > 8weeks of age), minced into 2mm 
cubes and incubated in 5 ml 6M HCl at 37°C for 90 minutes.  Tissue was homogenized 
through repeated pipetting and 25 ml H20 added.  After incubation O/N at 4°C, glomeruli 
in 5 X 1 ml of this solution were counted in a 35mm counting dish.  Total glomerular 
number per kidney was extrapolated mathematically from the mean of these five counts.    
   
RT-PCR 
RNA was extracted from E15.5 kidneys using absolutely RNA microprep kit 
(Stratagene #400805).  RT reactions were carried out using 1μg total RNA and primed 
with random hexamers.  PCR primer sets were designed to cross intron/exon boundaries 
except for Cited4 which only has 1 exon) to distinguish between cDNA and genomic 
DNA in case of contamination.  Annealing temperature was 60°C. Primer sets:    
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mCited1 F – GCA CTT GAT GTC AAG GGT GG 
mCited1 R – GAG AGA CAG ATC CCG GAG AC 
mCited2 F – GAG CAG AAA TCG CAA AGA CG 
mCited2 R- TGT TGA GCT TCT GCA GCT CG 
mCited4 F – TCA AGG TAG TGT CTA GCC CA 
mCited4 R – TGA GCT GTT GAG AGC CAC CA  
 
 
In situ hybridization  
In situ hybridization for Cited2 was preformed as previously described.  
(Dunwoodie et al., 1998; Hogan, 1994).  Digoxigenein labeled riboprobes were generated 
from a plasmid containing full-length mouse Cited2.  Tissue was treated with PK for 7 
minutes, and probes were hybridized O/N at 55°C.  After extensive washing tissues were 
incubated with AP-conjugated α digoxigenin antibody (roche # 1093274) at 1:1000, O/N 
at 4°C.  Tissue was developed with BM purple AP substrate (Roche # 1442074).      
 
Results 
 
Cited1 is expressed in the developing metanephric kidney  
   Using Cited1LacZ animals we created an expression map for Cited1 in the 
developing kidney by following β-galactosidase reporter activity (Fig. 5).  Previous work 
has shown that Cited1 mRNA is expressed in the ND at E10.5 (Dunwoodie et al., 1998).  
Whole mount analysis confirms expression in the ND at E11 (Fig. 5A) and indicates that 
as development of the UGS progresses, Cited1 expression becomes restricted to the 
metanephric kidney (Fig. 5B).   
During the initial stages of metanephric development Cited1 is present in the stalk, 
but not the tip, of the UB (Fig. 5C,D).  It is at this time that Cited1 is first detected in the 
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Figure 5 – Cited1LacZ expression in the  developing kidney.  Mapping of Cited1
expression E11.0 – adult using Cited1LacZ reporter mice.  A. E11.0; whole mount 
staining. Arrowhead-nephric duct  B. Whole mount of urogenital system from 
E15.5 embryo.  inset- magnification of kidney surface in E17.5 whole mount 
preparation.  C,D.  E11.0; Low (C) and high (D) power images of UB invading 
the MM. Arrowhead-UB, Arrow - MM. E,F. E12.0; Low (E) and high (F) power 
images of metanephrogenic region; Arrow - condensing MM, Arrowhead-
stromal MM.  G. E15.5; Low power image of metanephric kidney. H. E15.5; 
High power image of branching UB and MM differentiation. Arrow - cap 
mesenchyme, White arrowhead - stromal mesenchyme, black arrowhead –
condensed MM and stroma, Asterisk - RV.  I.  E17.5; Low power image of 
metanephric kidney.  J. E17.5; Nephrogenic zone K. P0; metanephric kidney at 
birth. L.  Adult; Low power image of cortical region.  FL- forelimb, Ad- adrenal 
gland, MS- mesonephros, MN- metanephros, Bl- bladder, ND- nephric duct, 
HG- hindgut, MM- metanephric mesenchyme, UB - ureteric bud.
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It is at this time that Cited1 is first detected in the MM where levels are low and 
its expression is patchy (Fig. 5C,D).  As these cells condense around the branching UB, 
expression becomes more robust, and by E12 Cited1 is expressed more widely in MM 
cells (Fig. 5E,F). Beginning at this early stage, its expression becomes limited to a subset 
of cells within the condensed MM that are most closely aggregated around UB tips, the 
so called ‘cap’ mesenchyme.   The restriction of Cited1 to the cap mesenchyme is striking, 
with an absence of expression in the condensed MM that lies in the cleft between UB tips 
(Fig. 5H) as well as the stroma.  This pattern persists throughout nephrogenesis as the UB 
branches dichotomously and induces the formation of new nephrons (Fig. 5G-J).  Cited1 
is not expressed in differentiated elements of the mature nephron or collecting system, 
and is absent in the adult kidney (Fig. 5I-L).   
 In order to verify the fidelity of the Cited1LacZ reporter mouse and analyze Cited1 
expression at the protein level, we characterized a commercially available anti-Cited1 
polyclonal antibody (Neomarkers).  The specificity of the antibody was confirmed by the 
complete lack of staining in Cited1 null kidneys, despite persistence of cap mesenchyme 
cells (Fig. 6A, B).  Using this antibody we mapped Cited1 protein expression over the 
same time course shown in the Cited1LacZ studies.  Fidelity of the reporter was confirmed 
and representative images are shown for E11 (Fig. 6C, compare to 5D) and E15.5 (Fig. 
6D, compare to 5H).  Like βgal reporter expression, Cited1 protein is restricted to the cap 
mesenchyme with no expression observed in the clefts between UB tips or in the 
surrounding stromal mesenchyme.    
This antibody was also a useful tool to evaluate the subcellular localization of 
Cited1 in the cap mesenchyme, as well as its regulation as these cells undergo epithelial  
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Figure 6 – Expression of Cited1 protein in the developing kidney. A,B.  
Characterization of anti-Cited1 antibody.  Kidneys from E15.5 embryos 
colabeled with rabbit αCited1 (red) and mouse αECadherin (green). A-
wildtype B- Cited1 null.  C, D.  Immnohistochemistry using rabbitαCited1 
antibody; C- E11.0 Arrowhead-UB, arrow - MM. (compare to Fig 1D), D-
E15.5 Arrow - cap mesenchyme, white arrowhead - stromal mesenchyme, 
black arrowhead – condensed MM and stroma (compare to Fig 1H).
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`differentiation.  In the cap mesenchyme, Cited1 is localized primarily in the cytoplasmic 
compartment (Fig. 7A, B).  As these cells begin to differentiate they migrate around the 
tip of the UB as the PTA and form the renal vesicle RV, marked by expression of E-
cadherin.  Dual labeling demonstrates a clear gradient of expression during this transition, 
with Cited1 levels highest in the cap mesenchyme, reduced in the region of the PTA and 
completely absent in the RV (Fig. 7B; also see Fig. 5H,J; 6D).  By staining sequential 
sections from E15.5 kidneys, we compared this expression pattern with that of two well 
characterized transcriptional regulators within the MM, Pax2 and WT1 (Dressler et al., 
1990; Kreidberg et al., 1993; Torres et al., 1995). The expression patterns of Cited1 and 
Pax2 are largely overlapping in the condensed mesenchyme, however Pax2 is also 
expressed in the cleft between UB tips, as well as in the UB itself (Fig. 7C,D).  While 
Cited1 is downregulated as cap cells begin to differentiate, Pax2 expression is robust in 
the forming RV.  Similarly, expression of Cited1 coincides with that of WT1 in the cap 
mesenchyme, although WT1 expression increases as MM cells differentiate to form early 
epithelial structures.  Furthermore, WT1 is present in glomerular podocytes, which do not 
express Cited1 (Fig. 7E,F).  
 
Cited1 is not required for nephrogenesis 
To evaluate the function of Cited1 in the developing kidney we analyzed 
Cited1LacZ/LacZ mice as this targeting strategy results in a complete loss of Cited1 protein 
(Howlin et al., 2006) (Fig. 6B). These studies were carried out using Cited1 null mice on 
the 129Sv/J genetic background as deletion of Cited1 on the C57Bl/6 background results 
in placental insufficiency and late gestation embryonic lethality (Rodriguez et al., 2004).  
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Figure 7 - Cited1 is downregulated as cap mesenchyme cells differentiate and 
is has an expression pattern distinct from Pax2 and WT1. A,B.  Colabeling for 
Cited1 (red) and E-Cadherin (green). A- E12.0 B- E15.5; Arrow - cap MM, 
Arrowhead- PTA , asterisk - RV. C-F.  E15.5; sequential sections colabeled for 
either Cited1 (red, C,E), Pax2 (red, D), or WT1 (red, F) and E-cadherin (green).  
Dapi stains nuclei blue.  C,D. Cited1 and Pax 2 sequential sections.  Arrow - cap 
MM, asterisk - RV; arrowhead - stromal MM.   E,F- Cited1 and WT1 sequential 
sections. Arrow - cap MM,  Asterisk - RV Arrowhead – glomerular podocytes, 
Dagger – S-shaped body.
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Cited1 null animals are born in the expected proportions and display no overt 
physical abnormalities (data not shown).  Examination of the kidney, both during 
development and in the adult, reveals that deletion of Cited1 does not disrupt proper 
organ formation (Fig. 8).  Tetragonolobus purpureas lectin staining demonstrates that 
proximal tubules form normally in Cited1 null mice and in numbers comparable to wild 
type (Fig. 8C-F, data not shown).  Formation of glomeruli is also unaffected in these 
animals.  As a measure of total nephrogenic capacity, we counted glomeruli in adult 
wildtype and Cited1 null animals.  No reduction in total glomerular number was observed 
in the absence of Cited1 (Table 2).   
 
Cited1 and Cited2 expression overlaps in the condensed MM    
 It is possible that the lack of a kidney phenotype in the Cited1 knockout animal is 
the result of functional redundancy through other members of this gene family. RT-PCR 
using total RNA from E15.5 kidneys demonstrates that Cited2 and Cited4 are also 
expressed in the developing kidney (Fig. 9A).  Preliminary results indicated that Cited2 is 
expressed in the MM, while Cited4 is expressed exclusively in the UB.  As a result, we 
focused on Cited2 as our primary candidate for redundancy.  The localization and 
analysis of Cited4 during kidney development will be discussed later in this chapter. 
Using in situ hybridization and Cited2LacZ/+ reporter mice, we asked to what extent Cited1 
and Cited2 expression overlapped in the developing kidney.  Whole mount analysis at 
E12.5 and E15.5 demonstrate that like Cited1, Cited2 is also expressed in the condensed 
MM, displaying the characteristic arc shape which marks this cell population. (Fig. 9B-E).  
Analysis of sections from E15.5 kidneys by in situ hybridization and β-Gal 
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Figure 8 – Deletion of Cited1 does not disrupt nephrogenesis. A,B. Low 
power H&E stained section from adult wildtype (A) and Cited1LacZ/LacZ (B) 
mice. C-F. Teragonoglobus purpureas lectin staining of proximal tubules 
(arrow) in E18.5 wildtype (C,E) and Cited1LacZ/LacZ (D,F) kidneys.  Boxes 
denote area of magnification.  Gl- glomeruli
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Figure 9. Cited2 expression in the developing and adult kidney. A. RT PCR 
using total RNA isolated from E15.5 kidneys.   B, C.  Whole mount LacZ
stained E12.5 UGS from Cited1LacZ/LacZ (B) and Cited2LacZ/+ mice.  Arrow –
condensed mesenchyme. D. Whole mount LacZ stained E15.5 kidney from 
Cited1LacZ/LacZ mouse.  E. Whole mount Cited2 in situ hybridization of E15.5 
kidney.   F. In situ hybridization for Cited2 on E15.5 kidney section.  Arrow –
condensed mesenchyme, Arrowhead – primitive nephrons.  G. Section of 
E15.5 Cited2LacZ reporter line; Arrow – condensed mesenchyme, Arrowhead –
differentiating epithelial structures.  H. High power images of individual 
branched UB tip in Cited2LacZ reporter line.  I.  Cited2LacZ expression in 
primitive glomeruli.  J. Cited2LacZ expression in the newborn papilla and 
glomeruli.  K. Cited2LacZ expression in the adult kidney.  L. High power 
image of designated area in (K).   
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staining shows Cited2 localized to the condensed mesenchyme, but also persisting in 
differentiated epithelial structures and glomeruli (Fig. 9 F-I). 
 The late stages (E17.5 onward) of kidney development are characterized by the 
patterning of the organ into distinct cortical and medullary elements.  The most inner part 
of the medulla is termed the papilla and is the home to the UB derived collecting system 
as well as distal nephron segments, such as the loop of Henle. During this stage Cited2 is 
upregulated in the forming papilla (Fig. 9J) In addition to its expression during 
development, Cited2 is also present in the adult kidney.  In the adult, Cited2LacZ is 
detected in tubular elements of nephrons in the cortical region positionally corresponding 
to the S3 segment of proximal tubules (data not shown).  Its most striking expression, 
however is in the papilla where it appears to be expressed in all cell types (Fig. 9K,L).   
 
Deletion of Cited2 does not disrupt branching morphogenesis or induction of new 
nephronic epithelia 
 
 Based on its overlapping expression pattern with Cited1, we focused on Cited2 as 
a candidate for redundant function in the cap mesenchyme.  The role of Cited2 during 
kidney development has not been previously evaluated.  Cited2 null mice die in utero 
beginning at e13.5 due to cardiac defects (Bamforth et al., 2001; Weninger et al., 2005), 
complicating embryonic studies and making analysis of adult kidneys impossible. 
Because of this we utilized an ex vivo system in which metanephric rudiments were 
isolated at E12 and grown in culture for a period of 5 days. Dual labeling with the UB  
marker calbindinD28K (red) and the pan-epithelial marker E-Cadherin (green) allows us to 
evaluate branching of the UB and the induction of nephronic epithelia. When these 
images are merged, branched UB tips appear yellow, expressing both markers, while 
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nephronic epithelial structures express only E-Cadherin and will be green. UB tips and 
new epithelial structures can then be quantified (Fig 10). 
 After 5 days in culture, there were no gross differences in overall morphology of 
metanephric cultures from wildtype, Cited1 null or Cited2 null animals (Fig. 11).  
Quantitative analysis revealed no difference in total number of UB tips or nephronic 
epithelial structures in Cited1 null cultures as compared to wildtype (Table 2).   Cultured 
kidneys from Cited2 null mice displayed an 18% reduction in nephronic epithelia 
compared to wildtype (Table 2; mean of 43 per kidney compared to 52 in wildtype).  
While this effect is statistically significant, the overall growth and UB branching of the 
rudiment was not significantly impaired and the MM was able to undergo 
epithelialization.   
 
Compound deletion of Cited1 and Cited2 does not disrupt inductive events in the 
developing kidney 
 
 Having established that Cited1 and Cited2 are not individually required for 
branching morphogenesis or nephron induction during kidney development, we generated 
compound mutant mice to test our hypothesis that these two proteins could substitute for 
one another in the MM.  During the course of these studies, we were able to generate 
Cited1LacZ/LacZ; Cited2+/- adult animals which had normal kidneys both in terms of 
morphology and glomerular numbers (data not shown, table 2).  This indicates that if 
Cited2 compensates for loss of Cited1 in the developing kidney, one copy is sufficient. 
 An organ culture system was again used to evaluate early nephrogenic events 
owing to the embryonic lethality of Cited2 homozygous deletion.  Generation of Cited1/2 
double homozygous null embryos for organ culture however, was problematic.   
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Figure 10– Method for analysis of UB branching and epithelial 
differentiation in cultured kidneys. A.  CalD28K labels the ureteric tree B.  
E-Cadherin labels all epithelial cells. C,D.  Merging images distinguishes UB 
tips and branches (double positive) from newly formed nephronic epithelia (E-
cadheirn positive), allowing for  evaluation and quantification of UB 
branching and formation of primitive nephrons.  Arrow – nephronic epithelia; 
Arrowhead – UB tip. 
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Figure 11 – Deletion of Cited2 does not perturb UB branching or induction of
new nephronic epithelia. Representative  images of 5 day metanephric organ 
cultures from WT A-C; Cited1LacZ/LacZ D-F; and Cited2-/- G-I mice.  Left column 
stained with UB marker CalbindinD28K, middle column stained with pan-
epithelial marker E-cadherin, right column merge of two images distinguishing 
UB epithelia from nephronic epithelia. 
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Mendelian analysis of our crosses (totaling 14 litters) dictates that of the 94 embryos 
recovered, 15 should be null for both Cited1 and Cited2.  We recovered, however, only 4 
Cited1/2 double homozygous null animals that survived until E12 (Table 3). We were 
able to recover tissue from an additional 8 reabsorbed embryos, 7 of which were double 
null.  This indicates that deleting both of these genes accelerates the embryonic lethality 
observed in Cited2 null animals, increasing the proportion of animals which die prior to 
the onset of kidney development.  Among those embryos that did reach E12 we did 
observe fewer branch tips and new epithelial structures in cultured kidneys (Fig. 12 G-I, 
table 2), though their overall morphology appears normal. We were not able to recover a 
sufficient number of Cited1LacZ/LacZ//Cited2-/- animals to demonstrate this to be a 
statistically significant difference.  On this basis we conclude that the key branching and 
inductive signaling events are intact in Cited1/2 double null kidneys.   
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Table 2.  Quantification of embryonic and adult kidney structures in wild type  
and CITED family mutant mice. * p < 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Distribution of expected and observed survival to E12.5 for genotypes of 
interest during generation of Cited1/2 compound mutant mice  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genotype n UB Tips Nephronic Epithelia n Adult Nephrons 
WT 11 70 ± 9 52 ± 9 5 7251 ± 182 
Cited1 -/- 10 79 ± 7 51 ± 5 4 7192 ± 169 
Cited2 +/- 13 78 ± 5 52 ± 6 4 7228 ± 188 
Cited2 -/- 13 67 ± 12 43 ± 7 * - n/a 
Cited1 -/-; Cited2 +/- 12 72 ± 6 49 ± 5 4 6987 ± 141 
Cited1 -/-; Cited2 -/- 2 48 ± 6   38 ± 7 - n/a 
Genotype Expected Recovered Reabsorbed 
WT 4-5 5 0 
CITED1-/- 15-16 17 0 
CITED2+/- 7-8 8 0 
CITED2-/- 3-4 5 1 
CITED1-/- // CITED2 +/- 31-32 37 0 
CITED1-/- // CITED2-/- 16-17 4 7 
Figure 12 - Compound deletion of Cited1 and Cited2 does not perturb UB 
branching or induction of new nephronic epithelia. Representative images of 
5 day metanephric organ cultures from WT A-C; Cited1LacZ/LacZ//Cited2+/- D-F; 
and Cited1LacZLacZ//Cited2-/- G-I mice.  Left column stained with UB marker 
CalbindinD28K, middle column stained with pan-epithelial marker E-cadherin, 
right column merge of two images differentiating UB epithelia from nephronic
epithelia. 
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Localization and role of Cited4 during kidney development 
 RT-PCR using RNA from E15.5 kidneys demonstrates that Cited4 is also 
expressed during nephrogenesis (Fig. 9A).  As previously discussed, preliminary results 
indicated that Cited4 was not expressed in the MM, but rather in the UB (Fig. 13C).    
Because of this, our redundancy studies focused on Cited1 and Cited2 as they overlap in 
the MM.  However, the expression pattern and role of Cited4 in kidney development has 
not been previously addressed.  To evaluate Cited4 during nephrogenesis we used 
Cited4LacZ reporter mice (Fig. 13A).  With this line, we mapped the expression of Cited4 
in the developing and adult kidney and asked whether deletion of Cited4 perturbed 
nephrogenesis.  The results of these studies are presented below.   
 At E10.5, prior to outgrowth of the UB, Cited4LacZ is detected in the ND (Fig 
13B).  It is not expressed in the initial outgrowth of the UB, but rather is upregulated in 
these cells after early branching events have occurred, and is clearly evident by E13.5 
(data not shown, Fig 13C).  Analysis of whole mount and sections from E15.5 kidneys 
shows that Cited4 is localized primarily to the tips of the UB, in a pattern reciprocal to 
that of Cited1 (Fig. 13D,E).  By E17.5 there is more staining in UB stalks, though not in 
all cells, as they elongate into the medulla en route to forming the collecting system (Fig. 
13F).  Cited4 expression is retained in the collecting system of the adult kidney (Fig. 
13G).  Using structural and marker analysis, we asked what cell type(s) is/are expressing 
Cited4 in the adult. Cited4LacZ positive structures do not coincide with Na/Katpse staining 
nephronic tubular elements.  In these sections blood vessels are identifiable by red blood 
cells in the lumen; we do not see Cited4LacZ activity in these structures either (Fig. 13H).   
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Figure 13.  Cited4 expression in the developing and adult kidney. A.
Targeting strategy for creation of Cited4LacZ reporter mice.  B. E10.5 whole 
mount embryo; arrow- nephric duct.  C. E13.5 whole mount kidney.  D. E15.5 
whole mount kidney.  Inset- high power image showing branched UB tips.  E.
Section of E15.5 kidney; arrow- UB tip, arrowhead- condensed MM, asterisk-
UB stalk.  F. Section of E17.5 kidney; arrow- UB tip, arrowhead – UB stalk.  G.
Adult kidney. arrow- Cited4 positive cells in medulla, entering papilla; 
arrowhead- Cited4 negative cells in cortex.  H. LacZ stained adult kidney 
colabeld with αNa/Katpase.  Arrow- Na/Katpase positive cells; arrowhead-
Cited4 positive cells; asterisk- blood vessel. Ad-adrenal gland, Cd-collecting 
duct, Cx-cortex, M-medulla, Ne-nephron, P-papilla, V-vessel.   
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This indicates that Cited4 is likely confined to the collecting system, a pattern that may 
be expected based on its expression in the developing UB.  
 The Cited4LacZ reporter insertion deletes the entire ORF of Cited4, and can be bred 
to homozygosity, producing null animals.  Cited4LacZ/LacZ mice are viable and fertile, 
indicating that Cited4 is not required for normal development.  Kidneys from these mice 
display no gross morphological defects and contain appropriate numbers of glomeruli 
(Fig 14G,H; able 3).  During the course of our Cited1 and 2 organ culture studies we 
evaluated Cited4 null kidneys for their ability to branch and induce nephronic epithelia in 
vitro.  As expected (based on the normal morphology of kidneys in adult Cited4 null 
animals) UB branching and epithelial differentiation were not perturbed in these cultures 
(Fig. 14A-F).     
  
Discussion 
In these studies we have evaluated the expression and role of the Cited family of 
transcriptional co-factors during kidney development in the mouse.  We have shown that 
Cited1 expression is initiated in the MM at E11 and is subsequently restricted to a subset 
of cells in the condensed mesenchyme closely aggregated around UB tips.  Its expression 
is downregulated as these cells undergo epithelial conversion, and is absent in all 
differentiated structures.  Despite its dynamic expression pattern, deletion of Cited1 does 
not disrupt kidney development.  We hypothesized that this was due to functional 
redundancy through other Cited family members.  Indeed, Cited2 and Cited4 are also 
expressed in the developing kidney.  Cited2 is expressed in the MM, though unlike 
Cited1 its expression persists in differentiated epithelial elements.  In contrast, Cited4 is  
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Figure 14.  Deletion of Cited4 does not disrupt UB branching or overall 
nephrogenic process. A-F – Representative images of e12.5 + 5 organ 
cultures stained with CalbindinD28K (A,D) and ECadherin (B,E).  Respective 
merged images (F,G).  Wildtype (A-C), Cited4-/- (D-F).  G,H. Low power 
H&E stained adult kidneys from wildtype (G) or Cited4-/-.mice.      
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expressed only in the tips of the UB, in those cells directly opposed to Cited1 expressing 
cells.  Owing to its overlapping expression pattern we focused on Cited2 as a candidate to 
compensate for loss of Cited1.  Neither deletion of Cited2 alone, nor in combination with 
Cited1 overtly disrupted branching morphogenesis or induction of new epithelia in 
cultured kidneys.  Furthermore, Cited4 null mice are healthy and viable and display no 
overt defects in kidney development.   
 The striking expression pattern of Cited1 is unique among other characterized 
transcriptional regulators of kidney development.  Unlike factors such as Pax2 (Dressler 
et al., 1990), WT1 (Kreidberg et al., 1993), and Six1 (Xu et al., 2003), Cited1 is not 
present in the MM prior to UB invasion.  After invasion, expression in the MM is patchy, 
but strong in the nephric duct.  Cited1 is not detected in UB structures after this point. As 
the UB undergoes initial branching events Cited1 is upregulated in the cap mesenchyme.  
These are renal progenitor cells that are directly responding to inductive cues from the 
UB and will soon undergo epithelial differentiation en route to becoming nephrons.  It is 
also thought that a group of cap cells are responsible for self-renewal of the MM, though 
this has not been definitively shown and no markers have been identified which 
distinguish this niche.  Expression of Cited1 within the cap mesenchyme persists 
throughout nephrogenesis, and overlaps with that of Six2, which is expressed in the 
condensed mesenchyme and is downregulated as these cells undergo differentiation (Self 
et al., 2006).  However, unlike Six2, Cited1 is restricted to the cap mesenchyme and is 
not expressed in cells in the cleft between UB tips.  
 Cited1 is downregulated as cap cells form the PTA and begin to undergo 
epithelial differentiation.  This contrasts Pax2 and WT1 which are expressed in the MM, 
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but are upregulated as early epithelial structures form.  Furthermore, WT1 is expressed in 
glomerular podocytes, both in the embryo and the adult.  Like Pax2, Cited1 is not 
expressed in the adult kidney. 
  Our studies show that Cited1 protein is primarily localized within the 
cytoplasmic compartment of cells within the cap mesenchyme (Fig. 7A,B, 15A).  This is 
consistent with data demonstrating the existence of a strong nuclear export signal in the 
C-terminal domain of Cited1 (Shi et al., 2006).  As the primary role of Cited family 
proteins relates to their ability to interact with and modify CBP and p300-dependent 
transcriptional responses (Braganca et al., 2003; Braganca et al., 2002; Shioda et al., 
1997; Yahata et al., 2001; Yahata et al., 2002), these findings suggest that nuclear export 
of Cited1 may serve to limit its transcriptional effects in the cap mesenchyme.  We have 
observed context dependent regulation of Cited subcellular localization in many settings 
(Fig 15).  Interestingly, Cited1 expression in Wilms’ tumors, a pediatric malignancy of 
renal origin characterized by the persistence of undifferentiated MM cells (Rivera and 
Haber, 2005), is primarily confined to the nucleus of these cells (Fig 15B).  This 
difference from normal nephrogenesis raises questions about the regulation and 
functional impact of changes in Cited1 localization during abnormal MM differentiation, 
as well as the possibility that Cited1 may serve a non-transcriptional function in the 
cytoplasm of cap mesenchyme cells.  Furthermore, we see differential localization of 
Cited1 in other organs during embryogenesis.  In the developing liver, Cited1 is detected 
in the cytoplasm of hepatoblasts (Fig. 15C).  Cited1 is also expressed in the developing 
heart in trabeculae as they delaminate from the wall of the left ventricle (Fig. 15D) 
Interestingly, in cells that are closest to the wall Cited1 is predominantly in found the 
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Figure 15. Context dependent subcellular localization of Cited1. Antibody 
staining using rabbit αCited1 antibody (red), where applicable, nuclei are 
labeled blue with dapi.  A. E15.5 kidney; Arrows – cap mesenchyme cells 
with  cytoplasmic Cited1. Epithelial cells labeled green with ECadherin.  B.
E12.5 Liver.  Arrows – examples of hepatoblasts with cytoplasmic
localization of Cited1.  C. E12.5 heart;  Arrow – Trabecular cell with nuclear 
localized Cited1, Arrowhead – cells near the muscle wall with cytoplasmic
Cited1.  D. Human Wilms’ tumor;  Arrow – example of blastemal cells with 
nuclear Cited1, Arrowhead – epithelial tubules. 
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cytoplasm, while in cells which have moved out into the trabeculae, Cited1 has shifted to 
the nucleus. Together, these data raise questions about the context dependent regulation 
of Cited1 localization and the role this plays in its function.    
 We relied on in situ hybridization and Cited2 and Cited4 LacZ reporter mice to 
analyze gene expression during kidney development as we were unable to detect Cited2 
and Cited4 in the developing kidney using antibody staining (despite published reports 
using the same antibodies in different tissues; (Bhattacharya et al., 1999; Yahata et al., 
2002).  Results from these experiments show that Cited1 and Cited2 expression overlaps 
in condensed MM cells, but that Cited2 persists in early epithelial structures and is 
present in glomeruli, as previously reported (Takemoto et al., 2006).  Cited2 is also 
expressed in the adult kidney, most prominently in the papilla.  Given the well 
characterized role of Cited2 as a mediator of hypoxic responses, this domain is not 
surprising; the papilla is known to be one of the most hypoxic regions in the body.    
 In contrast, Cited4 is not present in the MM, but is expressed most prominently 
in the UB tips.  This expression pattern is reminiscent of that of the tyrosine kinase 
receptor Ret, which is responsible for growth of the UB in response to MM derived 
signals (Pachnis et al., 1993; Schuchardt et al., 1996).  Cited4 expression is also 
maintained in the adult, where it is restricted to collecting ducts.  This is an extension of 
Cited4 expression during development as the UB gives rise to the collecting system. The 
function of Cited4 during development is unknown, however we show that homozygous 
null animals are viable and fertile.  These mice have morphologically normal kidneys and 
no impairment in UB branching or nephron induction.   
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 Based on these findings and the observation that Cited4 expression did not 
overlap with that of Cited1, we went on to evaluate whether Cited2 might be 
compensating for loss of Cited1 in the condensed MM of Cited1 null mice.  Initial studies 
evaluated Cited2 null mutant mice.  In examining cultured kidneys from Cited2 null 
animals we did see a decrease in the formation of new epithelial structures, though the 
overall morphology of the kidney was not perturbed.  This modest effect is likely due to a 
general underdevelopment of Cited2 null animals resulting from the associated cardiac 
and/or placental defects at this stage of development (Bamforth et al., 2001; Weninger et 
al., 2005; Withington et al., 2006).  Having established that Cited2 null mice did not have 
a major defect in nephrogenesis, we went on to ascertain whether loss of Cited2 
expression in a Cited1 null background would unmask a defect in nephrogenesis.  We 
were only able to recover a small number of Cited1/2 double null embryos during the 
course of our studies, as deletion of both genes resulted in earlier embryonic lethality 
than is observed in mice lacking only Cited2 (Bamforth et al., 2001; Weninger et al., 
2005) This effect may result from exacerbation of cardiac and/or placental defects in 
double null animals as Cited1 is also expressed in the developing heart and placental 
trophoblasts (Dunwoodie et al., 1998; Rodriguez et al., 2004).  However, despite some 
reduction in overall growth compared to wild type kidneys at the same gestational age, 
we did observe induction of nephronic epithelia and relatively normal UB branching in 
cultured metanephric kidneys that we were able to isolate from two of the Cited1/2 
double null embryos.  Furthermore, we were able to generate Cited1 null/Cited2 
heterozygote compound mutant mice and show that these had normal kidneys.  Taken 
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together these findings indicate that Cited2 is not required for nephrogenesis, and that its 
expression is not required to compensate for loss of Cited1 in the condensed mesenchyme.   
  In summary, these studies show that Cited1 is not required for kidney 
development and that deletion of Cited2 does not disrupt branching of the UB or the 
ability of the MM to undergo epithelial differentiation.  Furthermore, while compound 
deletion of Cited1 and Cited2 hastens the onset of embryonic lethality observed in Cited2 
null mice, it does not interfere with inductive events in the kidney.  Based on these 
findings we conclude that despite their dynamic expression patterns within the MM, both 
Cited1 and Cited2 are dispensable for nephrogenesis.  These data have now been 
accepted for publication (Boyle et al., 2007).   
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CHAPTER III 
 
CITED1 REGULATES CELL ADHESION TO THE EXTRA-CELLULAR MATRIX 
IN MCF7 CELLS 
 
Introduction 
Given the difficulties encountered in discerning the function of Cited1 in vivo, I 
have also used in vitro systems as an alternative approach to address this question.     
Ideally, this work would be carried out in a MM cell line, but such systems are 
notoriously difficult to develop and are inconsistent.  A good example of this problem is 
work I did using a rat MM cell line.  RIMM (rat inducible metanephric mesenchyme) 
cells are a conditionally immortalized cell line designed to undergo epithelial 
differentiation in response to UB derived factors (Levashova et al., 2003).  These cells 
express low levels of endogenous Cited1 and we were able to create stable lines 
overexpressing full-length Cited1 as well as two deletion mutants.  Despite encouraging 
preliminary data, however, we were unable to reproducibly induce RIMM cell 
differentiation.  Following several other unsuccessful efforts to use these cells to address 
the function of Cited1, they were discarded as a model system.  
Owing to these difficulties, we elected to use MCF7 cells to investigate the 
function of Cited1 in vitro.   MCF7 cells are a well characterized  (Jakowlew et al., 1997; 
Lynch et al., 2001; Tong et al., 2002) ductal breast cancer line which express high levels 
of Cited1, primarily in the cytoplasm.  We feel this line is a logical choice for functional 
studies given the role of Cited1 in maturation of the mammary gland during puberty (see 
Chapter one;  (Howlin et al., 2006).   
Using an siRNA based approach, we knocked down Cited1 in MCF7 cells 
(MCF7Cited1K/D) and found that this manipulation inhibits cell migration.  We show that 
this defect is related to the inability of MCF7Cited1K/D cells to adhere to selective 
components of the extra cellular matrix (ECM).  Cell adhesion is mediated through 
interactions between the ECM and integrin receptors expressed on the surface of the 
effector cell.  We asked whether reduced adhesion of MCF7CITED1K/D cells was associated 
with lower levels of candidate integrin subunits.   We did not observe changes in cell 
surface expression of β1, α1, or α6 integrin in MCF7Cited1K/D cells.  Furthermore 
phosphorylation of focal adhesion kinase (FAK), a critical step of integrin signaling 
following stimulation by ECM components, is not altered in knockdown cells.   
At this point, we do not understand the mechanism by which Cited1 regulates cell 
adhesion; however a clue may come from observation of the actin cytoskeleton during 
cell attachment.  At early time points we observe a reduction in filopodia formed when 
MCF7Cited1K/D cells are plated on type I collagen.  Together these data suggest a role for 
Cited1 in regulation of cell-ECM interactions.  This is an interesting candidate function 
for Cited1 given the role of cell movement in cap mesenchyme differentiation.  As cap 
cells form the PTA they move around the UB tip to the ventral aspect of the branch.  
Upon establishing early cell-cell and cell-matrix interactions here, PTA cells must move 
inward together and organize to form the RV.  The ability of these cells to execute this 
program is certainly mediated, at least in part, by the way they interact with the ECM 
environment in which they find themselves.  It is well understood that differential 
expression of ECM and integrin proteins plays an important role in kidney development 
(for review see (Kanwar et al., 2004), most prominently during formation of glomeruli 
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(Kreidberg, 2003).  Little is known, however about how these programs regulate cell 
adhesion and movement of the cap mesenchyme as it undergoes epithelial differentiation.     
 
Experimental Procedures 
 
Cell culture and siRNA transfection 
 MCF7 cells were maintained in DMEM containing 10% FBS (Gibco).  For 
knockdown of Cited1, cells were transfected with a pool of four RNA sequences 
designed to optimally target Cited1 transcripts (Dharmacon M-016022-00) or Gapdh 
transcripts as a control (D-001140-01-05).  Unless otherwise indicated, siRNA was 
introduced at a final concentration of 100 nM using Effectene (Qiagen) which allows for 
transfection in medium containing serum.  Briefly, cells were plated in 6 well dishes at 
2.25x105 cells/well the night before transfection.  The next afternoon, medium was 
removed and 1.6ml of fresh DMEM/10% FBS was added.  RNA was prepared according 
to the Quiagen protocol and added in 400μl of medium for a total volume of 2ml.  Cells 
were transfected O/N and washed gently two times with warm PBS before replacing the 
medium. 
 
Western blot analysis  
 For analysis of Cited1 protein levels in MC7FCited1K/D and MCF7GapdhK/D 
transfected cells, lysates were collected at indicated times after transfection in cold buffer 
containing 25mM HEPES, 1% Triton X-100, 5mM EDTA, 150mM NaCl, 1mM sodium 
orthovanadate, 20mM AEBSF, and 50mM NaF.  500ng of total protein was separated on 
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a 12% polyacrylimide gel and transferred to PVDF membrane (Biorad #1620177). Blots 
were blocked for 1 hour in 10% milk in TBST (TBS + 0.1% Tween-20) and probed with 
2H6, a mouse monoclonal antibody specific for Cited1 (generated in the Toshi Shioda 
Lab, MGH). Antibody was diluted 1:4000 in 5% milk/TBST and incubated O/N.  Blots 
were washed 3 times 10 minutes in TBST and incubated with HRP  conjugated goat α 
mouse secondary antibody for 1 hour, R/T.  After three more washes, blots were 
developed with Western Lighting Plus (PerkinElmer #NEL105), exposed for 1 minute 
and developed.  For analysis of βActin as a loading control, blots were stripped with and 
reprobed with a mouse monoclonal βActin antibody (Sigma clone AC-76).  For phopho-
FAK assays, lysates were collected from MCF7Gapdh and MCF7Cited1 cells which were; 
Attached (plated the night before the experiment); Suspended (attached cells trypsinized, 
washed twice in PBS and rotated at 37°C in SFM for 30 min.); and Reattached 
(suspended cells plated on Type I collagen (2.5μg/ml) and lysed 1 hr later).   
 
Migration assays  
To assess cell migratory ability we used a transwell system in which cells are 
added to the top of a suspended filter coated with ECM and assayed for their ability to 
migrate through it to the other side of the membrane.  The day before the assay 8 micron 
polycarbonate transwells (Corning Costar 3422) were coated with growth factor reduced 
Matrigel (BD biosciences 354230) diluted 1:10 in PBS (~0.85mg/ml) for 1 hour at 37°C.  
MCF7Cited1K/D and MCF7GapdhK/D cells were trypsinized, quenched with soybean 
trypsin inhibitor (1mg/ml) and washed 2 times in serum free medium.  1x105 cells were 
plated in triplicate on Matrigel coated wells in serum free medium and incubated for 
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times indicated.  After aspirating medium, filters were washed 1 time in PBS and fixed 
for 30 minutes in 3.7% formaldehyde in PBS at R/T.  After fixation filters were washed 
extensively with PBS and incubated with 2% crystal violet in 10% methanol O/N.  The 
next day wells were soaked in PBS and cells were removed from the top of the membrane 
using cotton swabs.  Migratory cells were visualized on the underside of the membrane 
and five high power fields were counted for each replicate.  Two-tailed t-test analysis was 
applied to the means of these counts to demonstrate statistical significance between 
groups.   
 
Adhesion assays  
 
Round-bottom 96 well dishes were prepared by coating with 100 μl of ECM 
component of interest at indicated concentrations in PBS and incubated O/N at 4°C.  The 
next day, wells were blocked with 2% BSA in PBS for one hour at 37°C.  MCF7GapdhK/D 
control and MCF7Cited1K/D transfected cells were collected, washed two times with PBS, 
and plated in triplicate onto matrix coated or BSA-only control wells at 1x105 cells in 100 
μl serum-free medium.  Cells were allowed to attach for 1 hour at 37°C, and washed with 
PBS until no cells remained in the BSA control wells.  Remaining cells were fixed for 20 
minutes in 4% PFA, and stained for 1 hour with crystal violet staining solution (1.5% 
crystal violet in 20% methanol). Cells were washed 5 times with 100 μl PBS and 
permeabilized with 5% acetic acid, O/N.  OD 595 was used to assess cell adhesion.   
 
Fluorescence Activated Cell Sorting (FACS) 
 
 MCF7GapdhK/D and MCF7Cited1K/D siRNA cells were trypsinized and quenched with 
10% FBS in DMEM, counted and allowed to recover in an excess of growth medium at 
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37°C for 30 minutes.  Cells were then washed in PBS + 2mM EDTA, spun down and 
resuspended in 100 μl of serum-free medium / 5x105 cells for each labeling reaction.   
Primary antibodies were as follows: MαH β1 integrin monoclonal- (Chemicon clone 6S6, 
MAB2253Z); MαH α1 integrin (Santa Cruz # SC33631); MαH α6 (Pharminigen 
#555734).  These were added at to suspended cells at 1:50 dilution and incubated at 4°C 
for 45 minutes with occasional mixing. Cells were washed 2 times with PBS/EDTA and 
resuspended in serum-free medium containing α mouse phycoerethrin (PE) (pharmagen) 
at a 1:50 dilution and incubated at 4°C for 20-30 minutes.  After 2 washes in PBS/EDTA 
cells were fixed for 2 minutes in 1% formaldehyde, spun down and resuspended in 300 μl 
PBS for FACS analysis, carried out at the Vanderbilt VA flow cytometry core.   
 
Immunofluorescense  
 For immunofluorescent analysis cells were prepared as described for adhesion 
assays and plated at 1.5x105 cells/well on glass coverslips coated with 2.5 μg/ml Type I 
collagen which had been blocked with 2% BSA in PBS.  After indicated times, cells were 
washed 2 times with warm (37°C) serum free medium and fixed in warm 4% 
paraformaldehyde (buffered in 10 mM PIPES; pH 7.1, 125 mM NaCl, 5 mM KCl, 1.1 
mM NaH2PO4, 0.4 mM KH2PO4, 2 mM MgCl2, 1 mM EGTA, and 5.5 mM glucose) for 
15 minutes at R/T.  After fixation cells were washed 2 times with PBS and permeabilized 
in 0.4% Trition X-100 in PBS for 10 minutes.  Coverslips were blocked for 1 hour with 
1% BSA in PBS and incubated with rabbit α Cited1 (1:200; Neomarkers) and/or FITC 
conjugated Phalloidin (1:500; Sigma P5282) for 1 hour at R/T.  Cells labeled with Cited1 
antibody were washed 3 X 5 minutes with PBS and incubated with G α Rabbit 
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Rhodamine X (Jackson Immunoresearch) secondary antibody.  Cells were washed again 
as above and mounted with Vectashield containing DAPI.   
 
Results and Discussion 
 
Knockdown of Cited1 in MCF7 cells 
 MCF7 cells are a ductal breast cancer cell line which expresses high levels of 
Cited1 endogenously (Fig. 16A; (Shi et al., 2006).  To determine if we could modulate 
Cited1 protein levels in these cells we transfected them with a pool of siRNA species 
designed to target Cited1 transcripts or control siRNA against Gapdh.  In initial 
experiments we used a dose range of siRNA to determine the optimal concentration for 
efficient knockdown (Fig. 16A).  48 hours after transfection we see Gapdh siRNA 
(150nM) has no effect on levels of Cited1.  In contrast, cells transfected with Cited1 
siRNA demonstrate a dose dependent response to increasing concentrations of siRNA.  
Cited1 protein is markedly reduced at the lowest concentration of 50nM and is almost 
completely eliminated using 100nM.  Increasing the concentration of siRNA to 150nM 
had no additional effect on knockdown efficiency, suggesting that there is a threshold to  
this effect.  Using a different Cited1 antibody (rabbit polyclonal, Neomarkers) we looked 
at Cited1 protein in transfected cells by immunofluroesense (Fig. 16B).  In control cells 
Cited1 levels were robust compared to a virtual absence of protein in cells transfected 
with Cited1 siRNA.  Like expression in the cap mesenchyme, we see that Cited1 is 
primarily localized in the cytoplasm.  Interestingly, Cited1 is not expressed in all MCF7 
cells indicating that there is some heterogeneity in this population.  These results  
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Figure 16. Knockdown of Cited1 in MCF7 cells. A. Western blot analysis 
using monoclonal αCited1 antibody (2H6) of Cited1 protein levels 48 hours 
after transfection of MCF7 cells with either Gapdh control siRNA or 
increasing concentrations of Cited1 siRNA.  Membranes were stripped and 
reprobed with βactin antibody to verify equal protein loading.  B.
Immunofluorescense of MCF7Gapdh and MCF7Cited1 cells using polyclonal 
αCited1 antibody.  Nuclei are labeled blue with DAPI; Arrow – Cited1 
positive cell, Arrowhead Cited1 negative cell. C. Time course of Cited1 
protein levels following transfection with 100nM Cited1 siRNA.  
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corroborate those obtained by western blot and indicate that Cited1 protein expression 
can be virtually abolished in MCF7 cells using 100nM siRNA.     
 Because knockdown is accomplished with a transient transfection and siRNA 
efficacy is known to wane as cells divide, we followed Cited1 protein levels over a 
timecourse following transfection to determine its duration of effect (Fig. 16C).  These 
studies indicate that maximum reduction of Cited1 is observed by 24 hours post 
transfection and persists for 5 days (approximately 3 doublings in our hands).  After 7 
days however, levels have returned to normal, suggesting that there is an absolute limit at 
which time the siRNA is no longer effective.  Based on these results we carried out the 
remainder of the studies presented here 24 hours post-transfection using 100nM Cited1 or 
Gapdh siRNA.   
 
Knockdown of Cited1 inhibits migration of MCF7 cells 
 After determining that Cited1 could be effectively knocked down in MCF7 cells 
we screened for changes in cell proliferation, apoptosis, and migration.  These processes 
are known to be important for maintenance and differentiation of cap mesenchyme cells.   
No changes were observed in cell growth or survival (data not shown).  Using a transwell 
system we asked weather knockdown of Cited1 altered the potential of MCF7 cells to 
migrate through a filter coated with Matrigel.  Four hours after plating we recorded a 
66% reduction in migration of MCF7Cited1K/D cells compared to control MCF7Gapdh cells 
Fig. 17A).  Interestingly, when cells were allowed to migrate for 6 hours, control cells 
continued to move through the matrix while Cited1 knockdown cells did not (Fig. 17A).  
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This suggested to us that the reduced migration ability of MCF7Cited1K/D cells was due to a 
defect in the initial step of cells migration, cell adhesion.    
 
MCF7Cited1K/D cells have a reduced capacity to bind selective ECM components 
 To test this hypothesis, we used adhesion assays to determine the capacity of 
MCF7Cited1K/D cells to bind different ECM substrates (Fig 17 B-F).  These experiments we 
designed in a dose/response fashion to look at adhesion over a range of substrate 
concentrations and determine optimal conditions for MCF7 cell adhesion.  Initial 
experiments were carried out using Matrigel given our observations that MCF7CitedK/D 
cells failed to migrate through this substrate.  When plated on Matrigel, MCF7Cited1K/D 
cells have a reduced capacity to adhere compared to MCF7Gapdh cells and this effect is 
observed over the entire range of Matrigel concentrations (Fig. 17B).  These data support 
our hypothesis that MCF7Cited1K/D cells fail to migrate because of an inability to bind the 
ECM.   
 Matrigel is a heterogeneous mixture of ECM components, primarily composed of 
Laminin I and Type IV collagen.  We therefore tested whether knockdown of Cited1 
selectively altered the ability of MCF7 cells to bind these individual ECM substrates.  
Results of these studies show a marked decrease in MCF7Cited1K/D cell adhesion to high 
concentrations of Laminin I, but no effect on binding to Type IV collagen (Fig. 17C.D)  
We went on to test adhesion to two other substrates, Type I collagen and fibronectin, both 
of which are expressed in the MM.  Furthermore, fibronectin is known to be important 
for branching morphogenesis in the developing kidney and salivary glands (Sakai et al., 
2003; Ye et al., 2004).  Like Matrigel, adhesion of MCF7Cited1K/D cells is reduced over the  
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Figure 17. Knockdown of Cited1 in MCF7 cells inhibits cell migration and 
adhesion to selective ECM components A. Graphic representation of 
migration data comparing MCF7GapdhK/D (blue) and MCF7Cited1K/D (green) cells 4 
and 6 hours after plating; * p<0.05.  B-F – Dose/response curves for 
MCF7GapdhK/D vs. MCF7Cited1K/D cell adhesion.  ECM component of interest 
noted above each graph. Y axis - OD595, X axis - ECM concentration (μg/ml).
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entire range of Type I collagen concentrations (Fig 17E).  In contrast, we see no 
difference in the ability of these cells to adhere to fibronectin (Fig 17F).  Together these 
data suggest that knockdown of Cited1 in MCF7 cells results in a specific defect (as 
opposed to a general defect) that alters their ability to adhere to selective components of 
the ECM.     
 
Attaching MCF7Cited1K/D cells have abnormal actin organization and impaired 
formation of lamelipodia and filopodia 
  
To visualize attaching cells we compared actin organization in MCF7GapdhK/D and 
MCF7Cited1K/D cells one and four hours after plating. For these experiments we used wells 
coated with 2.5μg/ml Type I collagen, as dictated by the dose/response curve generated in 
our adhesion assays.  At one hour MCF7GapdhK/D cells form numerous filopodia and 
lamelipodia, a feature of attaching cells (Fig. 18A).  In contrast MCF7Cited1K/D cells have a 
rounded appearance and no discernable organization of actin structures (Fig 18B).  At 
four hours control cells are well attached as indicated by the characteristic ‘spread’ 
morphology and cytoskeleton (Fig. 18C).  MCF7Cited1K/D cells do begin to form filopodia 
and lamelipodia-like fronts after four hours but, have not formed the numerous focal 
contacts observed in MCF7GapdhK/D cells (Fig 18D).  These data suggest that in the 
absence of Cited1, MCF7 cells do not form the characteristic actin structures required for 
cell attachment and migration, supporting a role for Cited1 in mediating cell-ECM 
interactions.    
 
 
Figure 18.  Actin organization in attaching MCF7GapdhK/D and MCF7Cited1K/D
cells. Cells plated on 2.5μg/ml Type I collagen and visualized at indicated 
times.  Green – FITC conjugated Phalloidin;   Blue- Dapi stained nuclei.  A.
MCF7GapdhK/D cells at 1 hr; arrow – filopodia, arrowhead – lamelipodia.  B.
MCF7GapdhK/D cells at 4 hrs; arrow – attached cells with characteristic actin
organization.  C. MCF7Cited1K/D cells at 1hr.  D. MCF7Cited1K/D cells at 4 hrs; 
arrow – filopodia, arrowhead lamelipodia.  
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Defects in MCF7Cited1K/D cell adhesion are not related to changes in cell surface 
expression of candidate integrins 
 
 Cell attachment and migration is mediated through interactions between the ECM 
and a diverse array of integrins expressed on the cell surface (for review see (Cox et al., 
2006; Moissoglu and Schwartz, 2006).  Integrin receptors are dimeric complexes of an α 
and a β subunit, the combination of which confers specificity for given ECM components.  
Upon binding of ECM ligands, these receptors initiate a well characterized signaling 
cascade which is propagated by members of the Rho/Rac family of small GTPases and 
culminates in reorganization of the actin cytoskeleton, allowing cell attachment or 
movement  
To address whether knockdown of Cited1 changed cell surface expression of 
integrin subunits we used flow cytometry.  For these studies we elected to look at three 
integrin subunits based on the data generated in our adhesion assays. β1 integrin is a 
broadly utilized subunit present in a wide variety of receptor complexes.  α1 is also 
widely used, but shows some preference for adhesion to collagen.  α6 is specific for 
interactions with Laminin I.   These studies were carried out by binding a phycoerythrin 
(PE) conjugated secondary antibody to cells labeled with subunit specific primary 
antibodies.  As a control, cells were incubated with PE secondary alone.  In control cells, 
the population appears to the left of the multigraph, indicating that no detectable PE is 
present (Fig. 19A, inset) In contrast, MCF7GapdhK/D cells labeled with either β1, α1, or α6 
antibodies display a strong rightward shift, indicating that all three receptor subunits are 
expressed on the cell surface (Fig. 19, left column).  In MCF7Cited1K/D cells we do not see 
a change in either the fluorescence intensity (indicative of the amount of antigen a given 
cell expresses) or the total number of cells that are positive for a given subunit (Fig 19, 
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Figure 19. Adhesion defects in MCF7Cited1K/D cells are not due changes in 
candidate integrin expression or phosphorylation of FAK. A-C. FACS plots 
of MCF7GapdhK/D vs. MCF7Cited1K/D examining cell surface expression of β1 (A), 
α1 (B), and α6 (C) integrin. X-axis is PE intensity; Y-axis is cell number.  
Inset A – Representative mulitgraph of negative control in which cells were 
incubated with secondary antibody alone.  D. Western blot analysis of FAK 
phosphorylation following cell attachment.  
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right column).   From these data we can conclude that migration and adhesion defects in 
MCF7Cited1K/D cells are not caused by a reduction in cell surface expression of β1, α1, or 
α6 integrin.   
An important early step in integrin-mediated cell attachment and migration is 
phosphorylation of focal adhesion kinase (FAK).  As a first step to interrogating this 
signaling pathway in this system we examined FAK phosphorylation in MCF7GapdhK/D 
and MCF7Cited1K/D cells during cell attachment (Fig 19D) In control and Cited1 
knockdown cells p-FAK is prominent in attached cells and disappears when cells are put 
into suspension.  Upon plating, FAK is phosphorylated at comparable levels in both cell 
groups.  These data indicate that if Cited1 regulates the cell adhesion/migration signaling 
pathway, it does so a level downstream of FAK.   
 
Conclusion 
In these studies we have used an in vitro system to uncover a role for Cited1 in 
regulation of cell adhesion and migration.   We show that Cited1 can be efficiently 
knocked down in MCF7 cells using siRNA and that this effect persists for five days.  
This manipulation results in inhibition of cell migration through the ECM, and is 
associated with a reduced capacity of cells to adhere to Type I collagen and Laminin I.  
During adhesion cells which lack Cited1 have abnormal actin organization and do not 
form characteristic lamelipodia or filopodia.  To try and understand a mechanism for the 
effect of Cited1 on cell adhesion we asked whether cell surface expression of candidate 
integrins were effected in MCF7Cited1K/D cells.  No discernable changes were detected in 
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levels of β1, α1, or α6 integrin.  Furthermore, FAK phosphorylation, an important early 
step in cell adhesion, was not effected in the absence of Cited1.   
 These studies demonstrate a role for Cited1 in regulation of cell migration and 
adhesion and provide an in vitro platform for the investigation of its function.  Though it 
is unclear if these data reflect an in vivo role for Cited1 in cell-ECM interactions, we do 
know that cell migration and adhesion are important components of early MM 
differentiation.  These processes are not well understood.  This work has also yet to 
identify a mechanism by which Cited1 regulates cell adhesion.  This is important given 
the insight it could offer relating to the general biology of Cited1.  Future experiments 
should focus on identifying this mechanism and will be discussed in Chapter 5.   
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CHAPTER IV 
 
GENERATION OF Cited1-CreERT2 MICE REVEALS DISTINCT PATTERNS OF 
CAP METANEPHRIC MESENCHYME CELL FATE 
 
 
Introduction 
One of the fundamental issues outstanding in the field of kidney development is 
the origin of the more than 20 specialized cell types required to make a functional organ.  
We have a general appreciation that nephronic epithelia arise from the condensed 
mesenchyme and that the collecting system is of UB origin, but specific cell fates and 
differentiation patterns have not been carefully addressed.  We do not know if the cap 
mesenchyme gives rise to different cell types at different times during development, or if 
the pattern of nephron induction and growth is consistent throughout kidney development.  
It is unclear whether primitive nephron structures (such as the RV) are already distinct 
entities, containing all of the parent cells needed to make a nephron, or if certain 
segments are populated later by additional cells from other sources.  There has also been 
some debate within the field regarding the possibility that condensed mesenchyme 
progeny participate in formation of the collecting system.  Furthermore, the origin of 
other populations in the adult kidney, such as endothelial and interstitial cells, is unclear.   
There has been a limited attempt to address some of these issues using in vitro 
lineage tracing experiments in the past.  Early attempts used a retroviral system to deliver 
a LacZ reporter to whole kidney rudiments from rat, and showed that after a period of 
growth, labeled cells are found in nephronic tubules as well as collecting duct (Herzlinger 
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et al., 1992).  However, as there is no way to verify that only MM cells (and not UB cells) 
were infected with the virus initially, we cannot be sure that this reflects actual lineage 
patterns in vivo.  This system was improved by isolating rat MM, infecting it with the 
LacZ retrovirus and recombining this tissue with UB in culture (Qiao et al., 1995).  Again, 
these studies showed that the MM could give rise to nephronic epithelia and some 
collecting duct cells.  The difficulty of ensuring that no UB cells were brought along with 
the isolated MM again makes it unclear if this is an actual reflection of in vivo events.  
Aside from terminal fate, the question of progenitor cell potential in the 
developing kidney is underscored by the issue of cap mesenchyme repopulation.  As 
discussed above, due to the iterative nature of UB branching during kidney development, 
new MM must be continuously available for each round of nephron induction.  It is 
unclear whether this in an intrinsic property of the cap mesenchyme or if this niche is 
repopulated by new cells migrating to each bud tip, from the stromal mesenchyme, for 
instance.     
For these reasons we saw the expression domain of Cited1 as an unique 
opportunity to lineage trace a distinct group of progenitor cells in the developing kidney 
and address many of the questions discussed above.  To do this we used a transgenic 
mouse strategy (described in detail below) to express a tamoxifen inducible form of Cre 
recombinase (CreERT2) specifically in the Cited1 expression domain.  By crossing these 
mice to a conditional reporter line (such as Rosa26RLacZ) and inducing recombination 
with tamoxifen, we can ‘tag and track’ cap mesenchyme cells and ask questions about 
their fate, their patterns of differentiation and their capacity to renew.   
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 Recently there have been two other published reports of mice which express Cre 
in the MM; Pax3-Cre (Grieshammer et al., 2005), and Rar2b-Cre (Kobayashi et al., 
2005).  While both of these reports make brief mention of cell lineage from this 
population, each of these genes is expressed in a much wider domain than Cited1, 
encompassing all nephrogenic mesenchyme prior to UB invasion.  This breadth makes 
them less advantageous to address the specific fate of the condensed mesenchyme.  
Furthermore, both are constitutively active, lacking the temporal control of gene deletion 
present in our system. 
Here we describe the creation and characterization of Cited1-CreERT2 transgenic 
mice.  We have identified one founder line which expresses CreERT2 in the appropriate 
domain and demonstrates the expected pattern of recombination in response to tamoxifen.  
This founder carries a four copy block of transgene integrations which is stably 
transmitted following the F1 generation.  Using these mice, we lineage traced the overall 
potential of the cap mesenchyme by labeling cells at E13 and examining their fate in 
adults.  This injection time point reveals widespread cap mesenchyme lineage in the adult 
kidney and demonstrates that cells in all segments of the nephron can be derived from 
this population.  These data also demonstrate that elements of renal endothelium and 
collecting duct are not of cap mesenchyme origin.  By tagging cells at various points 
during development, we have shown that at early stages cap mesenchyme gives rise to 
deep nephrons, those structures whose distal elements reach all the way into the papilla.  
In contrast, nephrons which arise after E18 become superficial nephrons, whose distal 
segments do not extend past the medulla.  Furthermore, the extensive nephronic progeny 
of cap cells tagged at E13 suggests that these cells are also capable of self-renewal.  By 
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examining embryonic timepoints, in which we can visualize the turnover of the cap 
mesenchyme, we have shown this to be true.   
This mouse strain also allows one to circumvent a key problem in the study of 
kidney development in the mouse.  As discussed in chapter one, many factors that are 
expressed at later stages of MM differentiation are also required for early inductive 
events (Table 1).  As a result, deletion of these genes usually leads to the complete or 
near-complete loss of any kidney whatsoever.  This makes analysis of gene function in 
vivo at later stages impossible.   Utilizing Cited1-CreERT2 mice in a Cre/LoxP strategy of 
conditional targeting, one can control the tissue-selectivity (cap mesenchyme) and timing 
(tamoxifen inducible) of gene deletion.     
 
Experimental Procedures 
 
Generation of BAC transgene and transgenic animals 
Specifics of BAC targeting vector and modification are discussed at length in the 
Results and Discussion section.  In general, our manipulations were preformed as 
previously described (Lee et al., 2001).  Briefly, a BAC (RP23-204G22, mouse 129/SvJ; 
Invitrogen) covering the entire Cited1 locus, as well as 190 kb of 5’ and 30 kb of 3’ 
genomic sequence, was electroporated into the EL250 E. coli which carries the 
temperature sensitive λ phage Red recombination system and arabinose inducible Flp 
recombinase.  A targeting vector containing a CreERT2-IRESeGFP-frtTETRfrt cassette 
flanked by 500 bp homology arms corresponding to the Cited1 locus at the transcriptional 
start site was electroporated into EL250 cells containing the Cited1 BAC and induced to 
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recombine by 42°C heat shock. Positive clones were treated with arabinose to activate 
inducible Flp recombinase within the EL250 cell, removing the TetR cassette.  Small 
scale preparation of BAC DNA was carried out using standard alkaline lysis techniques.  
For restriction digest DNA was cut O/N and resolved using PFGE, run for >12 hours. 
 For generation of transgenic animals, Cited1-CreERT2 BAC was purified using 
cesium chloride maxiprep techniques.  Following removal of EtBr using butanol 
extraction, DNA was subjected to a series of spins using Centriprep size exclusion 
columns to concentrate BAC DNA in TE pH 7.4.   Dilutions of purified BAC DNA were 
cut with Not1 and subjected to PFGE against a standard to estimate concentration.  BAC 
DNA was diluted to 1ng/ml for pronuclear injection of zygotes derived from Fvb mice as 
described (Vintersten et al., 2004).  Injected zygotes were implanted into pseudopregnant 
ICR females and allowed to come to term.         
 
Mouse lines and tamoxifen injection 
Transgenic mice generated using Cited1-CreERT2-IRESeGFP BAC DNA are 
hereafter referred to as Cited1-CreERT2 mice.  Rosa26RLacZ/LacZ (R26RLacZ) mice were 
obtained from Jackson Laboratories (Soriano, 1999).  For treatment of pregnant females, 
tamoxifen (Sigma T5648) was dissolved by sonication in 10% EtOH / 90% sunflower oil 
at a concentration of 15 mg/ml.  100 μl (1.5 mg) was injected intraperitoneally (IP) into 
pregnant R26RLacZ females at times indicated.  As tamoxifen injection compromises the 
ability of mice to have natural birth, pups were delivered by C-section at E19.5-E20 (day 
of vaginal plug appearance counted as E0.5).  After pups were breathing independently 
they were transferred to foster mothers who had given birth the day before and had begun 
nursing.  The overall success rate of fostering was >80%.   
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Genotyping and quantitative genomic PCR   
Founders and subsequent offspring were genotyped using the following primer 
sets; Cre:  5’ GGC GCG GCA ACA CCA TTT TT; 3’ TCC GGG CTG CCA CGA 
CCAA.  Rosa26RLacZ:  5’A  AAA GTC GCT CTG AGT TGT TAT; 5’B  GCG AAG AGT 
TTG TCC TCA ACC;  3’ GGA GCG GGA GAA ATG GAT ATG.  Transgene copy 
number was estimated using TaqMan based real-time PCR using genomic DNA as 
described (Chandler et al., 2007).  Briefly, the chloramphenicol cassette within the BAC 
vector was amplified using a custom primer set from Applied Biosystems (5’: GCA CAA 
GTT TTA TCC GGC CTT TAT T; 3’: GTC TTT CAT TGC CAT ACG GAA CTC).  To 
estimate copy number, triplicate ΔCT values for the chloramphenicol cassette relative to 
a genomic DNA control, Jun kinase, were compared to the ΔCT values of known 
quantities of BAC DNA prepared to estimate copy number equivalents. 
 
β-Gal staining  
See Chapter Two.   
 
Antibody Staining  
For dual labeling, kidneys were isolated, cut bilaterally along the sagital axis (for 
adults) and fixed for 1 hour in 4% formaldehyde in PBS at 4°C.  Following fixation, 
tissue was rinsed in PBS and subjected to a sucrose gradient of first 15% (4 hrs) and then 
30% (O/N) in PBS at 4°C.  After embedding in OCT, frozen sections were cut at 8 μm 
onto charged slides.  For staining, slides were thawed, rinsed in PBS and blocked in 10% 
goat serum (Vector Labs) in PBS for 1 hour.  Tissue was incubated with primary 
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antibody O/N at 4°C, washed 3 times in PBS, and incubated with secondary antibody for 
1 hour at R/T.  After washing in PBS, tissue was mounted with Vectashield mounting 
medium containing DAPI (Vector Labs.)  When antibodies used for co-labeling were of 
the same species, sequential sections were used.  
   
Antibodies 
Rabbit αCited1 1:250 – Cap mesenchyme; (Neomarkers #RB-9219)   
Mouse αCre 1:100 – CreERT2 expressing cells (Covance # MMS 106P) 
Mouse αGFP – GFP expressing cells (Molecular Probes clone MAb3E6, #A11120) 
Rabbit αβGal 1:5000 - Cap mesenchyme derived cells; (Cappel #55976, Lot 04993) 
Mouse αNa/K ATPase (α1 subunit) 1:250 – Broad marker of nephronic tubular epithelia;  
(Upstate #05-369) 
 
Rat αPCAM 1:250 - Endothelial cells; (BD Biosciences #553370)  
Hamster αPodoplanin 1:500 - Glomerular epithelia (Angiobio # 11033) 
WT1 1:100 – Glomerular podocytes; (Santa Cruz #SC192) 
Rabbit αAquaporin 1 – 1:250 – Thin limb and proximal tubule; (Chemicon  # AB3065) 
Rabbit αAquaporin 2 – 1:250 – Collecting duct; (Alpha Diagnostics #AQP21-A) 
 
Results and Discussion 
 
Generation of targeting vector and BAC recombinant transgene  
To create Cited1-CreERT2 mice we utilized BAC transgenesis.  This technique 
allows us to insert a gene of interest into the Cited1 locus and drive its expression using 
the same promoter elements that regulate endogenous transcription.   BACs are 
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advantageous for this purpose because they can be modified in bacteria and contain large 
regions of genomic DNA up- and downstream of a given gene, so that we need not know 
precisely where promoter elements lie (for review on BAC transgenesis see (Copeland et 
al., 2001; Giraldo and Montoliu, 2001; Liu et al., 2003).  The BAC we modified for 
creation of the Cited1-CreERT2 transgene (RP23-204G22) was selected based on the 
relative position of the Cited1 locus within its genomic sequence (Fig. 20A).  This BAC 
contains ~ 190 kb of upstream and ~30 kb of downstream genomic sequence, which we 
presume has a high probability of containing the regulatory elements to drive appropriate 
gene expression from the Cited1 locus.  For modification, the BAC was purified from 
DH10B E. coli (in which it is maintained) and electroporated into the EL250 E. coli 
strain (Lee et al., 2001).  This strain is engineered to carry both a set of heat inducible 
genes that mediate homologous recombination and arabinose inducible FLP recombinase, 
which allow for the excision of unwanted Frt flanked sequences within the BAC.  
Following electroporation, DNA was purified from chloramphenicol resistant clones 
(carried by all BACs in this library) and digested with BamH1, which cuts the BAC 
several times.  This results in a predictable banding pattern, identical to that of BAC 
DNA that was purified and digested from the parental DH10B strain (Fig. 21A).  This 
confirms stable introduction of our BAC into the EL250 strain (EL250Cited1BAC). 
The targeting vector used to insert CreERT2 into the BAC Cited1 locus was built 
on pBS-TetR (Fig 20B).  This plasmid is a derivative of pBluescript SK(+) which carries 
a tetracycline resistance cassette flanked by Frt (FLP recombinase recognition) sites.  5’ 
and 3’ homology arms for the Cited1 locus (~500bp each) were generated by PCR from 
genomic DNA and inserted on either side of the TetR cassette in pBS-TetR.  Homology  
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BFigure 20.  Selection and targeting of BAC for generation of Cited1-
CreERT2 transgenic mice. A. Screenshot of UCSC genome browser showing 
relative position of Cited1 locus (asterisk) on the X-chromosome and the 
available BAC clones (brackets) which cover this region.  The BAC we 
selected for targeting is highlighted.  B. Schematic of  targeting vector and 
site of recombination within the BAC Cited1 locus. Cut sites discussed in the 
text are highlighted in red.  Not to scale.  
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arms were designed to remove the Cited1 transcriptional start site and the subsequent 12 
bp within the BAC, but do not delete any additional coding sequence (Fig 20B).  We used 
this strategy to avoid removal of any intronic regulatory elements within the Cited1 locus.  
The resulting intermediate construct (pBSTetR-C1TV) can be used as a general platform 
for targeting Cited1 in a BAC, as any gene of interest can be placed between the 
homology arms for insertion into the locus. 
  In these studies we have cloned a CreERT2IRESeGFPpolyA cassette into the Xho I 
site of pBSTetR-C1TV (pBSTetRC1TV-ERT2).  This cassette encodes Cre recombinase 
fused to the ligand binding domain of the estrogen receptor, so that Cre translocates to the 
nucleus (and thus is active) only in the presence of the estrogen analog tamoxifen (Feil et 
al., 1996; Feil et al., 1997).  In addition it contains an internal ribosomal entry site (IRES) 
allowing for independent translation of eGFP, which can then be used as a marker of 
transgene expression.   
 For BAC targeting, the AflII fragment of pBSTetRC1TV-ERT2 was purified (Fig. 
20B) and electroporated into EL250Cited1BAC cells which had been grown at 42°C to 
induce expression of the recombination gene set.  Positive clones were identified by dual 
tetracycline and chloramphenicol resistance and screened by PCR using primers that lie 
upstream in the 5’ genomic region and downstream in the CreERT2cassette, respectively.  
Restriction digest can also be used to confirm insertion.  In this particular BAC, there is a 
Not I site ~3.5 KB upstream of the Cited1 transcriptional start site, and recombination of 
the targeted locus adds a downstream Not1 site just after the TetR cassette (Fig. 20B).  As 
a result, the correctly targeted locus gives rise to a ~9.5 kb band when digested with Not I.  
However, Not I digestion also releases the vector backbone for this BAC library, which is  
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Figure 21. Introduction and modification of BAC into EL250 cells. A. 
BamH1 digest of BAC DNA purified from DH10B (parental strain) and EL250 
(recombination strain) following electroporation.  B. Not1 digest following 
insertion of CreERT2-IRES-eGFP into BAC Cited1 locus and removal of TetR
with Flp recombinase;  Arrow- vector backbone +/- insert, Asterisk- vector 
insert doublet not resolvable by PFGE,  Arrowhead – insert following removal 
of TetR cassette, Dagger- genomic DNA. C, D.  Not1 digest following 
sequential removal of 2 cryptic loxP sites; Arrow – vector bandshift resulting 
from insertion of zeocin (C) and kanamycin (D) resistance cassettes, Arrowhead 
– parental vector backbones.  For all modifications results from two independent 
clones are shown.  
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also ~9.5 kb.  These two bands are not resolvable by PFGE, and appear as a single band, 
even when the gel is run for >20 hours (Fig. 21B, lanes 2 and 4).  The Frt sites on either 
side of the TetR cassette allow for its removal from the targeted locus in the EL250 strain 
(see above), preventing any unwanted effects on gene expression or function resulting 
from its proximity to the gene of interest.  This excision reduces the size of the CreERT2 
insertion by ~2.6 kb, making the vector and insert bands clearly distinguishable using 
PFGE (Fig. 21B).   
 Two additional modifications were made to the targeted BAC through 
homologous recombination using a system developed in the Michelle Southard-Smith lab 
(Vanderbilt University).  These changes resulted in the removal of cryptic LoxP sites that 
are present in the vector backbone of the parental BAC.  As BACs tend to integrate into 
the host genome as concatamers, these sites could inappropriately mediate self-excision 
of a transgene expressing Cre recombinase and should therefore be removed.  Plasmids 
which target these sites and confer kanamycin and zeocin resistance, respectively, were 
introduced sequentially as described above.  These modifications result in an increase in 
the size of the vector backbone, which can be observed as an upward band shift after Not 
I digestion and PFGE (Fig. 21 C,D).  Unlike the TetR insertion, these cassettes were not 
removed from the BAC given that they are a considerable distance (<30kb) from the 
locus of interest and would not be predicted to interfere with transgene expression or 
activity.   
 The resulting BAC contains CreERT2-IRESeGFP in the Cited1 locus and is 
devoid of the TetR cassette and cryptic LoxP sites.  This BAC was then used as a 
transgene to create Cited1-CreERT2 animals through pro-nuclear injection.  Zygotes for 
 99
injection were derived from super-ovulated female mice on the FVB genetic background, 
which has been previously shown to support BAC integration (Auerbach et al., 2003).  
Of the ~200 zygotes injected and implanted into pseudo-pregnant ICR females, 29 live 
births were obtained (11 ♀/ 18 ♂). These animals were screened by PCR for the presence 
of CreERT2, resulting in 6 potential founders (2♀/ 4♂; data not shown). 
 
Characterization of Cited1-CreERT2 founders    
 For initial analysis of transgenic recombination potential we utilized Rosa26R 
LacZ reporter mice (R26RLacZ). These animals carry a floxed stop cassette between the 
ubiquitously expressed Rosa26 promoter and a β-Galactosidase cassette (Soriano, 1999).  
When exposed to active Cre recombinase the stop cassette is excised, resulting in LacZ 
expression in cells that underwent a recombination event and all of their progeny.  For 
characterization of Cited1-CreERT2 transgenic animals, R26RLacZ mice were crossed to 
potential founders and injected with 1 mg of tamoxifen at E12 and E13.  Pregnant mice 
were sacrificed at E15.5 and kidneys removed from embryos for whole mount LacZ 
staining.  Embryonic tissue was also collected to assess germline transmission of the 
transgene by PCR.  Of the 6 potential founders, 2 did not transmit the transgene to their 
offspring and were discarded (data not shown).  In the remaining four lines we saw three 
distinct patterns of recombination in the developing kidney (Fig 22A-C).  In line 349 
whole mount staining revealed a relatively even distribution of recombined cells 
throughout the kidney, which is what we would expect given that we intended to label a 
subset of cells which would then only have ~72 hours to divide.  Line 351 showed much 
more intense LacZ staining throughout the kidney, while in line 336 it appeared as if all 
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cells had been labeled.  In all three lines we observed recombination in the ureter (Fig 
22A-C), likely a result of early Cited1 expression in the ND and primary stalk of the UB, 
which gives rise to the ureter (Fig. 5 C,D).  In addition line 336 shows recombination in 
vascular structures surrounding the ureter (Fig 22C).  This suggests that this line 
expresses CreErT2 outside of the Cited1 expression domain as there is no evidence these 
cells arise from cap mesenchyme.   
To determine in which cell types recombination was occurring in these lines we 
sectioned our whole mount preparations.  In line 349 recombination has occurred in the 
condensed MM, but not in the UB (Fig. 22D).  In contrast, widespread recombination in 
the condensed MM and the UB was observed in lines 351 and 336 (Fig. 22E,F).  At this 
point line 336 was discarded as it seemed to induce recombination during early kidney 
development clearly outside of the Cited1 expression domain, lacking the specificity 
needed for careful lineage tracing.  In addition the fourth line which transmitted the 
transgene in the germline, 346, also demonstrated the same broad pattern of 
recombination (data not shown).   
There are a number of possible explanations for recombination occurring in the 
UB at this stage in line 351.  One of these is that at this early injection timepoint (E12) 
there is residual Cited1 expression in UB stalks resulting in recombination in a large 
percentage of UB structures, distinct from the expected recombination observed in the 
ureter.  This effect may not be observed in line 349 due to differences in levels of 
transgene expression.   If this were the case, we would expect that by injecting tamoxifen 
at E15, we would extinguish recombination in the UB in line 351, given that Cited1 is not 
expressed in any UB structures at this point (Fig.  5G, 6A).   
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Figure 22.  Characterization of Cited1-CreERT2 founder lines. Potential 
founders were crossed to R26RLacZ reporter mice.  A-C. Whole mount staining 
of E15.5 kidneys following tamoxifen injections at E12 and E13.  Line 
designation listed bottom left; Arrow- ureter, Arrowhead – vasculature 
surrounding ureter.  D-F. Sections of A-C, respectively; Arrow- condensed 
MM, Arrowhead – UB. G, H. Sections of E18.5 kidneys following E15 
tamoxifen injection.  Line designation listed bottom left; Arrow- condensed 
MM, Arrowhead- RV, Dagger- UB, Chevron- Differentiating epithelial 
elements (tubular epithelium and glomeruli). I, J.  Cre (+) newborn animals 
whose mothers were not injected with tamoxifen in line 349 (I) and 351 (J). 
Arrow- recombined cells.  
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To test this hypothesis, we again crossed our potential founders (349 and 351) 
with R26RLacZ mice, injected tamoxifen at E15, and observed the pattern of 
recombination at E18 (Fig. 22G,H).  In line 349 we observed recombination in the 
condensed MM, RVs, early epithelial structures, and primitive glomeruli (Fig. 22G).   
This pattern reflects the cell types we would expect to arise from the cap mesenchyme.  
In contrast, line 351 again showed widespread recombination in the UB, as well as robust 
recombination in the condensed MM and primitive nephrons (Fig.  22H).  This shows 
that recombination in the UB in line 351 is not a consequence of early expression of 
Cited1 in the nephric duct or UB stalk but results from either ectopic expression of the 
transgene or loss of transgene regulation by tamoxifen, rendering it constitutively active.  
Both of these possibilities can be readily addressed.   
By analyzing NB Cited1-CreERT2 / R26RLacZ embryos whose mothers have not 
been injected with tamoxifen, we can determine if CreERT2 is active at any time during 
kidney development in the absence of tamoxifen.  This would include activity in the 
nephric duct and UB stalk which could explain the UB recombination observed in line 
351.  In line 349 we did not observe any labeled cells in Cre positive NB offspring of 
mothers who had not been injected with tamoxifen (Fig. 22I).  In line 351 there were a 
few labeled cells in the absence of tamoxifen, but it does not appear that this level would 
be sufficient to produce the widespread pattern of recombination we observed  in these 
mice (Fig. 22J).   
The other possibility is that in line 351 CreERT2 is ectopically expressed in UB 
structures at later stages of kidney development.  To test this we looked at Cre expression 
in both lines using antibody staining in E15.5 kidneys.  The specificity of this antibody  
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Figure 23.  CreERT2 and Cited1 expression at E15.5 in offspring from two 
potential founder lines. A,D,G – Rabbit α Cited1; B,E,H – Mouse α Cre; C,F,I 
- Overlays of respective images.  A-C – Transgenic line 349, Cre (-) animal; 
Arrow- cap mesenchyme.  D-F – Transgenic line 349, Cre (+) animal.  Arrow –
cap mesenchyme, Arrowhead – UB.  G-I – Transgenic line 351, Cre (+) animal. 
Arrow – cap mesenchyme, Arrowhead – UB. 
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was confirmed by staining kidneys which were Cre negative (Fig 23A-C).  In line 349 we 
observed that expression of CreERT2 was restricted to the cap mesenchyme in a pattern 
that exactly overlaps that of Cited1 (Fig. 23D-F).  By contrast, we detect CreERT2 in both 
the cap mesenchyme and the UB in line 351 (Fig. 23G-I).  This demonstrates that 
recombination in the UB at multiple injection timepoints in line 351 most likely resulted 
from ectopic expression of CreERT2.  Because this pattern is not reflective of endogenous 
Cited1 expression, line 351 was discarded.  All subsequent studies werecarried out in 
mice derived from founder 349 (hereafter referred to as Cited1-CreERT2 mice).   
 
Propagation and copy number transmission of Cited1-CreERT2  
 Because BACs contain large segments of genomic DNA (on the order of 200kb) 
and tend to integrate into the genome as concatamers, transmission of an equal number of 
copies of the transgene from parent to offspring can be variable and is often not 
established until after the F1 generation (Doug Mortlock, personal communication).  To 
characterize copy number transmission in Cited1-CreERT2 mice we utilized a genomic 
quantitative PCR method developed in the Doug Mortlock laboratory.  This assay 
compares the copy number of the CAM cassette, contained in all BACs from this library, 
to that of a housekeeping gene.  By normalizing samples in this way we can infer 
transgene copy number in a given animal and track its transmission to offspring (Fig. 24).   
 Using this method we determined that our founder (349, F0) carried five copies of 
the CreERT2 transgene, and by crossing this mouse to a wildtype female, we examined the 
transmission pattern of these elements (Fig. 24, F0-F1).  Analysis of the F1 generation 
showed that among Cre positive animals there were mice that received one,  
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Figure 24. Schematic of Cited1-CreERT2 transgene copy number 
transmission from founder (F0) through generation four (F4). Legend 
indicates copy number per mouse determined by genomic quantitative PCR. 
Every mouse resulting from each cross was not evaluated, only those males 
pre-determined to be Cre (+).  Numbers in parenthesis indicate distribution of 
mouse type resulting from each cross.  Where this is not noted, all mice are 
listed indicating stable transmission of transgene (34966-9; 96471-4)
5 copies
4 copies
1 copy
W wildtype
♂
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♀W F0
♂♀W F3♂ ♂9647;(4/10) (4/10)(2/10)
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four, or five copies of the transgene.  This suggests that there is a block of four copies of 
CreERT2 which segregate together and a single copy that segregates individually.  Indeed, 
in crosses of F1 males carrying four copies to wildtype females, all Cre positive progeny 
carried four copies of the transgene (Fig. 24 F1-F2, left column).  Furthermore, in 
intercrosses using an F1 four copy male with a single copy F1 female, the resulting Cre 
positive mice carried either one or five copies.  By crossing a five copy F2 male with a 
wildtype female we observed the four copy block again segregating independently from 
the single copy.  This block was then transmitted intact from the F3 to the F4 generation 
(Fig. 24 F2-F4, right column).  Based on this analysis we conclude that our founder carries 
a four copy block of the Cited1-CreERT2 BAC which is stably transmitted following the 
F1 generation and can be propagated through multiple generations of mice.  Interestingly, 
analysis of transgenic line 351, in which we saw ectopic expression of Cre and 
inappropriate recombination in the UB, revealed that these animals carried 17 copies of 
the transgene (data not shown).  It is possible that high integration levels in this line have 
resulted in inappropriate transgene expression.   
 
eGFP expression in Cited1-CreERT2 transgenic kidneys   
 As discussed above, the BAC transgene we constructed to make these mice gives 
rise to a bicistronic message with IRES-eGFP fused downstream of CreERT2.  This 
strategy results in independent translation of eGFP, which can be used as an acute marker 
of transgene expression.  Our initial attempts to detect eGFP signal during founder 
analysis were unsuccessful.  It is possible, given our copy number and transmission 
analysis, that we were using mice for these studies that contained only one copy of 
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CreERT2.  Perhaps the level of transgene expression achieved with one copy does not 
result in detectable levels of eGFP.  This problem could be compounded by the fact that 
translation from an IRES is often reduced when compared to a standard ribosomal 
recognition site.    
Having established stable transmission of a four copy block of CreERT2 we asked 
whether eGFP was detectable in these animals.  Using formaldehyde-fixed kidneys from 
E15.5 transgenic mice we carried out two experiments to detect eGFP.  By simply 
looking for fluorescence in these sections, we saw that eGFP expression was clearly 
evident in the cap mesenchyme (Fig 25A).  eGFP signal was also detected on sections 
which had been stained with an α GFP antibody, confirming translation of eGFP (Fig. 25 
B-D).  However, the strength of the eGFP signal was markedly reduced following 
antibody staining, and required long exposures to detect (4 seconds compared to 0.75 
seconds in tissue which was not subjected to antibody staining).  This suggests that some 
component of the staining process quenches eGFP signal.  From these studies we 
conclude that eGFP can be used in Cited1-CreERT2 animals as an acute marker of 
transgene expression, and that this is best accomplished on tissue which has been fixed 
but otherwise untreated.      
 
The cap mesenchyme gives rise to cells in all segments of the mature nephron 
 To test the total potential of cap mesenchyme cells, we crossed Cited1-CreERT2 
mice to the R26RLacZ reporter line and injected pregnant females at E13.  At this time we 
know that Cited1 is strongly expressed in the cap mesenchyme which should lead to 
widespread recombination.  Waiting until 6 weeks of age to examine cell lineage (by  
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Figure 25.  eGFP expression in Cited1-CreERT2 transgenic kidneys. E15.5 
kidneys fixed in formalin for 1 hour.  A. eGFP signal on section which has 
been formalin fixed only. Approx. exposure 0.750 sec. B. eGFP signal on 
section colabled with mouse αGFP antibody.  Approx. exposure 4 secs. C.
αGFP antibody stain. D. Merged image of B & C, plus Dapi marking nuclei.  
UB – ureteric bud  
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Figure 26.  Lineage tracing of cap metanephric mesenchyme labeled at E13.
Pregnant Cited1CreERT2/R26RLZ mice were injected with tamoxifen at E13.  
Resulting Cre positive mice were analyzed by LacZ staining at 6 weeks of 
age.  A. Low power sagital image of kidney.  All subsequent pictures are 
higher power images of this kidney.  B. Cortex and cortico-medullary
junction.  C. Medulla and papilla.  D. Cortico-medullary junction.  E.  High 
power image of papilla,  Arrow – cap mesenchyme derived cells which have 
reached the papilla.  F. High power image of cortico-medullary region; Arrow 
– cap mesenchyme derived cells with elongated morphology, Arrowhead –
cap mesenchyme derived cells with with proximal tubular morphology.  G.
High power image of cortex; Arrow – glomeruli.  H. Individual glomeruli and 
associated proximal tubule; Arrow – proximal tubule.  
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which time nephrogenesis is well completed), allows us to ascertain the complete 
potential of Cited1 expressing cap cells.  Analysis of X-Gal stained sections reveals that 
by injecting at E13 we achieved widespread recombination in a large percentage of 
nephrons, and that the cap mesenchyme gave rise to multiple cell lineages in the adult 
kidney, including cortical and medullary cell types (Fig. 26).  Generally speaking, some 
of these lineages were immediately evident based on morphology and position, including 
proximal tubules and cells within glomeruli (Fig. 26G, H).  In the medulla however, cell 
types were more difficult to distinguish morphologically.  Here, descending nephronic 
elements and collecting ducts bundle with their associated vasculature as they move 
through the medulla into the renal papilla (Fig. 26B-D)  This region contains LacZ 
positive cells which have a thinner, more elongated phenotype (Fig. 26D-F).  This 
morphology and position is consistent with multiple cell types in the adult kidney 
including loop of Henle and vascular endothelium.  Furthermore, it was difficult to 
distinguish nephronic epithelia from collecting duct in deeper parts of the kidney by 
simply evaluating cell morphology.   In order to determine exactly which cell types do or 
do not arise from the cap mesenchyme we utilized an antibody against β-Gal and cell 
type specific markers for dual immunofluoresence.   
 Previous to these studies, there has been a general appreciation that progenitor 
cells within the cap mesenchyme give rise to multiple cell types within the mature 
nephron, based on observations using labeled cells in rat tissue recombination 
experiments. It is not surprising then, that β-Gal colocalized with Na/K ATPase 
expressing cells, a broadly expressed marker of nephronic epithelia (Fig.  27A-C). Cap 
mesenchyme derived cells within glomeruli coincide with podoplanin-expressing cells,  
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Figure 27.  Cap cell lineage in specialized nephronic epithelia.  Pregnant 
Cited1CreERT2/R26RLZ mice were injected with tamoxifen at E13 and lineage 
was analyzed in the adult.  A-C. Cortical region stained with αβgal (A) or 
αNa/K atpase (B) antibody and respective merged image (C).  Insets – identical 
staining demonstrating a tubular structure in cross section.  D-F. High power 
image of glomeruli stained with αβgal (D) or αPodoplanin (E) antibody and 
respective merged image (F); Arrow- glomerular epithelial cells of cap 
mesenchyme origin. G. Glomeruli stained with αWT1 antibody.  G’. Sequential 
section to (G) stained with αβGal antibody.  Arrow – cells in which βgal and 
WT1 are colocalized (podocytes). H. Papilla stained with αAqp1 antibody.  H’.
Sequential section to (H) stained with αβgal antibody; Arrow - cells in the loop 
of Henle in which are of cap mesenchyme origin.  I.  Cortex stained with X-Gal 
and αAqp1.  Arrow – proximal tubule cells of cap mesenchyme origin.  L.
Papilla stained with X-Gal and αAqp1.  Arrow – thin ascending limb of cap 
mesenchyme origin.    
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indicating lineage in a broad segment of the glomerular epithelial compartment (Fig. 
27D-F).   Furthermore, staining on sequential sections using a podocyte-specific antibody 
detecting WT1 shows that these highly specialized cells within the glomerulus are also of 
cap mesenchyme origin (Fig.  27G, J).        
Aquaporin 1 marks both cortical proximal tubule elements as well as thin limb.  
Staining of sequential sections with an αAqp1 antibody and β-Gal reveals that the thin 
limb within the papilla is derived from the cap mesenchyme (Fig. 27H, K)  This lineage 
connection can be demonstrated with greater resolution by performing 
immunoperoxidase staining on sections which have been X-Gal stained.  Using this 
method, we detected cap derived loop cells in the medulla that also expressed Aqp1 on 
their cell surface (Fig. 27J).  In the β-Gal positive cells that express Aqp1 were also 
observed in the cortex, demonstrating cap mesenchyme lineage in the proximal tubule 
(Fig. 27I).  Together, these studies show that the cap mesenchyme gives rise to a wide 
variety of epithelial cell types in the nephron including proximal, distal and glomerular 
elements.  This is the first time these fate connections have been explicitly defined using 
a genetic tagging method.    
 
Cap mesenchyme does not give rise to renal endothelium or contribute to collecting 
duct 
 
To determine if the cap mesenchyme gives rise to cell types outside of the 
nephron proper, I again used a β-Gal antibody and cell specific markers for dual 
immunofluorescent labeling.  Based on morphology and envelopment of RBCs, we 
speculated that some of the elongated cells we see in our X-Gal stained kidneys could be 
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Figure 28.  The cap metanephric mesenchyme does not give rise to renal 
endothelial cells or contribute to collecting duct. Pregnant 
Cited1CreERT2/R26RLZ mice were injected with tamoxifen at E13 and lineage 
was analyzed in the adult.  A-C. Glomerulus stained with αPCAM (A) or αβgal 
(B) antibody and respective merged image (C).  D-F. High power image of 
medulla stained with αPCAM (D) or αβgal (E) antibody and respective merged 
image (F); Arrowhead- PCAM positive blood vessel.  Arrow - βgal positive 
cells of cap mesenchyme origin. G. Medulla stained with αAqp2 antibody.  G’. 
Image (G) merged with dapi to identify nuclei.  H. Sequential section to (G) 
stained with αβGal antibody. H’. Image (H) merged with dapi to identify nuclei; 
Arrowhead – Aqp2 positive collecting duct. Arrow- βgal positive cells of cap 
mesenchyme origin. I.  Medullary/ papillary junction stained with X-Gal and 
αAqp2.  J. Magnification of (I) Arrow – LacZ positive cells of cap mesenchyme 
origin; Arrowhead – Aqp2 positive collecting duct.      
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glomerular endothelial cells.  Furthermore, the origin of renal endothelium is not well 
understood.  A lineage connection between the cap mesenchyme and the renal 
endothelium would be unprecedented, and our system allows us a unique opportunity to 
directly address this question.  In these studies we asked whether there were cap derived 
β-Gal positive cells that also expressed the endothelial specific marker PCAM.  Using 
this analysis we saw no evidence of overlap between these cell populations, in either 
glomeruli (Fig. 28A-C) or in medullary vessels (Fig 28D-F).  We conclude that the 
elongated cells present in our X-Gal stained lineage traced kidneys are in fact nephronic 
elements (i.e. thin limb) that are running alongside their closely associated vasculature 
(Fig. 28F).   
 As discussed in the Introduction, there has been speculation that the cap 
mesenchyme can contribute to the collecting duct, though results from previous lineage 
tracing studies are inconclusive and none were carried out using a genetic system in vivo.  
The system we have developed offers a direct opportunity to address this question 
carefully. By using the collecting duct specific marker Aquaporin 2 and asking whether it 
was expressed β-Gal-positive cells we determined whether the cap mesenchyme can 
indeed contribute to the collecting system.  Staining for Aqp2 and β-Gal on sequential 
sections showed no overlap between these two markers (Fig 28G/G’, H/H’).  We can 
examined this in greater resolution by using the Aqp2 antibody on top of sections which 
have been X-Gal stained (Fig 28I, J).  This analysis again demonstrated that while 
nephrons and collecting ducts are closely opposed as they move through the medulla into 
the papilla,  β-Gal marked cells and collecting ducts are mutually exclusive (Fig. 28J).   
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Fig 29.  Progressive fate of cap mesenchyme cells during the course of 
kidney development.  Cited1-CreERT2 mice were crossed to R26RLacZ 
reporter animals and injected with 1.5mg of tamoxifen at times indicated in 
lower left.  Mice sacrificed at 6 weeks of age.  Arrows - deep nephronic
elements in papilla.  Arrowhead – cortio-medullary junction where 
superficial nephrons stop.  Cx- cortex, Md- medulla, P- papilla
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From these studies we conclude that the cap mesenchyme does not give rise to renal 
endothelial cells or cells within the collecting system.   
 
Patterns of nephron formation during development   
 A fundamental question that was addressed using this lineage-tracing system was 
whether cap mesenchyme cells have different fate patterns at different times during 
development.  To test this we crossed Cited1-CreERT2 mice with R26RLacZ reporter mice, 
injected tamoxifen at varying timepoints during embryogenesis, and examined lineage 
connections patterns at six weeks of age.  At the earliest injection timepoint, E11, we saw 
that the cap mesenchyme gave rise to cells in all parts of the kidney, including cortical 
and medullary regions (Fig 29A).  Furthermore, the relatively low number of nephrons 
labeled by injecting at this point is consistent with the fact that only a few cells in the 
condensing MM express Cited1 at E11 (Fig. 5C,D).   As previously discussed, injecting 
at E13 labeled a large percentage of total nephrons, with cap derived cells again present 
from the cortex to the papilla (Fig 29B).  An E15 injection gave a similar result, although 
fewer total nephrons were labeled (Fig. 29C).  This is to be expected, as it is well known 
that many nephron precursors arise from the cap mesenchyme prior to E15.  When 
tamoxifen was injected at E18, however, we observed a different pattern of labeling in 
which cap- derived cells were present in the cortex and the medulla, but did not extend 
into the papilla (Fig. 29D).  This likely represents a distinction between so called ‘deep’ 
and ‘superficial’ nephrons.  Deep nephrons extend all the way into the papilla where their 
loops of Henle turn and ascend to the collecting duct junction.  Superficial nephrons 
contain all of the same cell types as deep nephrons, but do not extend past the boundary 
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between the medulla and the papilla.    These studies indicate that deep nephrons arise 
only during the early phase of nephrogenesis and that later stages are marked by the 
formation of superficial nephrons. These data do not tell us if both types arise during 
early stages of nephron induction, while only superficial structures are generated from the 
cap later, but are consistent with the prevailing model of two distinct phases of 
nephrogenesis.   
 
The cap metanephric mesenchyme is a self-renewing progenitor cell population 
 One of the striking things uncovered in the studies described above is the high 
percentage of total nephrons in the adult that were labeled with an E13 injection.  The 
adult mouse has (depending on strain) on the order of 8-10,000 nephrons, yet at E13 there 
are perhaps only 16 cap condensations containing renal progenitor cells.  As discussed 
above, this speaks to the need for a mechanism to either maintain or recruit new cap cells 
for induction by the UB.  If new cap mesenchyme was generated by recruiting cells from 
an outside population, then labeling at E13 would only tag the cap mesenchyme present 
at that time, resulting in a correspondingly low number of nephrons labeled in the adult 
kidney.  Instead, an E13 injection resulted in a large percentage of labeled nephrons in 
the adult (Fig 26A).  This lineage connection strongly suggests that cells in the cap 
mesenchyme not only give rise to nephronic epithelia, but also divide to produce new 
renal progenitor cells.   
To address this question, we again crossed Cited1-CreERT2 mice with the 
R26RLacZ reporter and injected tamoxifen at E13.  This time, however, we examined cell 
lineage at E19.5.  This timepoint is advantageous because it contains well differentiated  
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Figure 30.  The cap metanephric mesenchyme is a self-renewing progenitor 
cell population. Pregnant Cited1-CreERT2/R26RLZ mice were injected with 
tamoxifen at E13 and lineage was examined at E19.5.  A. Low power image of 
entire kidney.  Arrow – cells of cap mesenchyme origin which are moving into 
distal locations.  B. Image of nephrogenic zone and primitive cortico-medullary
junction;  Black arrow – cap derived cells which have reached the medulla, 
black arrowhead – s-shaped body, white arrowhead – RVs and comma-shaped 
bodies. White arrow – cap metanephric mesenchyme. C. Nephrogenic zone.  
Arrows – cap mesenchyme.  D. High power image of branched UB.  
nephronic epithelia as well as immature structures and cap mesenchyme.  In these mice 
we see that most of the cap mesenchyme progeny are located in the cortex, with only a 
few distal cells which have reached the forming papilla (Fig. 30A).  This is consistent 
with a proposed model in which nephrons are born and build up in the cortex during 
embryonic development, while later stages are characterized by the growth and extension 
of these primitive structures (Cebrian et al., 2004).  Looking closely at the nephrogenic 
zone and early cortico-medullary boundary we see three general zones in which cap 
mesenchyme progeny lie (Fig. 30B).  In the deepest zone are the cells that arose from the 
cap first, as they have gone through the stepwise process of nephron induction and are 
already extending into the medulla.  The next zone is characterized by primitive nephrons 
in the later stages of induction, most notably s-shaped bodies.  In the most outer zone we 
see cap derived cells in the early stages of differentiation including RVs and comma-
shaped bodies.  This pattern demonstrates that since the injection at E13, at least 3 
generations of nephrons have arisen from the cap mesenchyme.  If outside cells were 
being recruited to repopulate this niche then the cap cells present at this time (E19.5, 6.5 
days after injection) would not be labeled, as the originally tagged cells would have been 
depleted by the induction process and replaced with unlabeled cells.  Instead, we see that 
almost all of the cap mesenchyme in these kidneys is labeled, strongly supporting the 
hypothesis that they are progeny of the cap cells labeled at E13 (Fig. 30C,D).   
To rule out the possibility that labeling of cap mesenchyme at E19.5 in these mice 
was due to inappropriate, persistent nuclear translocation of Cre, we examined its 
subcellular localization following tamoxifen injection (Fig. 31).  For these studies mice 
carrying transgenic litters were injected between E14 and E15 and sacrificed at indicated  
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Figure 31.  Kinetics of Cre subcellular localization following tamoxifen
injection in Cited1-CreERT2 kidneys.  A-D.  Cre localization using antibody 
staining in E16.5 kidneys; A’–D’ corresponding images overlaid with the 
nuclear stain Dapi.   A. Uninjected animal; Arrow- example of cell with 
cytoplasmic Cre localization.  B.  Cre localization 8 hours after injection; 
Arrow – cell with nuclear and cytoplasmic Cre, Arrowhead – cell with nuclear 
localization of Cre.  C. Cre localization 24 hours after injection; Arrowhead –
cell with nuclear localization of Cre.  D. Cre localization 4 days after injection.  
Arrow – cell with cytoplasmic Cre   
125
A
’
D
B
’
D
’
C
’C
B
A
0 
ho
ur
s
8 
ho
ur
s
24
 h
ou
rs
96
 h
ou
rs
U
B
U
B
U
B
U
B
U
B
mαCre
mαCre / Dapi
126
times.  In uninjected mice, antibody staining detects cytoplasmic localization of Cre (Fig. 
31A, A’).  8 hours after injection, we begin to see nuclear translocation of Cre, although 
some cells still have predominantly cytoplasmic expression (Fig. 31B,B’)   By 24 hours, 
most cells have Cre strongly localized to the nucleus (Fig. 31C, C’) Importantly, by 96 
hours Cre has left the nucleus and is thus no longer active (Fig. 31D, D’) These results 
are consistent with previously published data in using this system  (Hayashi and 
McMahon, 2002).  These data rule out the possibility that cap cells are labeled at E19.5 
due to persistent recombination, and strongly support a model of the cap metanephric 
mesenchyme as a self-renewing progenitor cell population.   
 
Conclusion 
 Here we have described the creation of Cited1-CreERT2 transgenic mice.  These 
animals express tamoxifen inducible Cre recombinase in the Cited1 expression domain, 
which is the cap metanephric mesenchyme in the developing kidney.  This line represents 
a novel tool in the field and allows for lineage tracing of renal progenitor cells as well as 
temporally and spatially controlled gene deletion.   Using these mice we have 
investigated the fate of the cap mesenchyme at varying points during development.  We 
show that this population is capable of giving rise to cells in all segments of the adult 
nephron, and that by tagging cells at E13 we see lineage in most mature nephrons.  
Furthermore, we show that nephrons which arise prior to E18 are capable of becoming 
deep nephrons, extending well into the papilla, while after E18 new tubules adopt the 
superficial fate.  Lastly, we show for the first time that the cap metanephric mesenchyme 
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is capable of self-renewal, meaning that all specialized epithelia in the mature nephron 
likely arise from a common progenitor pool.      
 These findings are important as this is the first study to completely trace the 
lineage of cap mesenchyme in mice and demonstrate in vivo that specialized epithelia in 
all segments of the nephron can be derived from this cell population.  Our observation 
that after E18 the cap mesenchyme gives rise to only superficial nephrons is striking, and 
supports a model of distinct phases of nephrogenesis.  Most importantly, we provide 
strong evidence that during development cells within the cap mesenchyme give rise to 
new rounds of renal progenitor cells.  Aside from the studies presented here, the Cited1-
CreERT2 mouse can now be used as a powerful tool to examine cap cell behavior real-
time in organ culture, and as a platform for temporally controlled gene deletion in the cap 
metanephric mesenchyme.       
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CHAPTER V 
 
 
DISCUSSION and FUTURE DIRECTIONS 
 
 The primary focus of my research has been to investigate the function of the Cited 
family of transcriptional co-factors in the developing kidney.  Though this question 
remains largely unanswered, I think the work presented here adds important information 
and tools to the field of kidney development. It also offers ample future opportunities to 
further understand the normal and abnormal regulation of this process.  Below, I will 
discuss the key findings of my research and their implications, while interspersing 
interesting future experiments which they suggest.      
 
Cited1 in the developing kidney 
We show that Cited1, Cited2, and Cited4 are expressed dynamically in the 
developing kidney, in cell types which are of high interest to the field at large.  The 
expression domain of Cited1 is particularly striking, as it is upregulated in the MM 
response to UB invasion and is restricted to a subset of the condensing mesenchyme 
called the cap mesenchyme.  These are the cells that aggregate most tightly around the 
branched ends of the UB and undergo a characteristic pattern of differentiation in 
response to factors secreted by UB tips.  This expression domain is unique among other 
characterized factors present in the MM.  The closest pattern is that of Six2 (Self et al., 
2006), which is also expressed in the cap structure.  Six2, however, is expressed in the 
uninduced mesenchyme and in the clefts between the UB tips.  Based on this expression 
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domain, an interesting experiment would be to fate map Six2 expressing cells as we did 
with Cited1 expressing cells (chapter 4) and compare the two lineage patterns (in fact, 
tools to do such an experiment are currently being developed in the Andy McMahon 
laboratory at Harvard).  It is possible that the cells in the clefts between UB tips have a 
distinct lineage, such as interstitum, which would be absent in our lineage studies.      
 In the cap mesenchyme, Cited1 is primarily localized in the cytoplasmic 
compartment and is downregulated during the earliest phases of progenitor cell 
differentiation.  During this stage, cells move to the ventral aspect of the UB tip and form 
first the PTA and then the RV.  By the time cells reach this initial stage of polarization, 
Cited1 is completely absent.  This pattern of subcellular localization and dynamic 
expression is interesting in general, but may have broader implications when considering 
data generated in our laboratory regarding the pediatric malignancy Wilms’ tumor.  This 
lesion is characterized by the inappropriate persistence of undifferentiated MM which 
becomes the aggressive component of the tumor.  Cited1 expression is retained in these 
cells in nearly all Wilms’ tumors examined.  Together with our data in the developing 
kidney, this strongly suggests that Cited1 expression is associated with early, 
undifferentiated renal progenitor cells.  Furthermore, in Wilms’ tumor, Cited1 is 
primarily found in the nucleus.  This raises questions about the regulation of Cited1 
expression and localization and the impact it has on normal and abnormal kidney 
development.   
As no mouse model of Wilms’ tumor exists, it would be interesting to see if 
persistent Cited1 expression in the cap mesenchyme was sufficient to create nephrogenic 
rests and predispose mice to this lesion.  Using our Cited1-CreERT2 system we could 
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address this question.  To do this we would create a transgenic or knock-in mouse which 
had a floxed stop cassette in between a ubiquitously expressed promoter (such as R26R) 
and full-length mouse Cited1.  By crossing this mouse to the Cited1-CreERT2 animal we 
could ‘turn on’ persistent expression of Cited1 in cells that would normally downregulate 
it in response to differentiation cues.   This is essentially an in vivo recapitulation of what 
we have done using a TAT fusion protein to overexpress Cited1 in cultured kidneys in 
vitro.  In these experiments Cited1 blocked the formation of new epithelial structures and 
expanded the condensed MM.  Based on this, these types of experiments seem likely to 
yield important information about the role of Cited1 in the MM, regardless of whether 
they result in mice predisposed to Wilms’ tumor.   If these mice did yield an interesting 
phenotype, one could imagine several modifications we could make to the expression 
construct to test different questions regarding the function of Cited1.  For instance, an 
epitope tagged version of the construct could be introduced to facilitate ChIp on CHIP 
assays in the search for MM specific Cited1 target genes and/or protein binding partners. 
Furthermore, deletion mutants could be expressed to ask in vivo questions about 
structure/function relationships.  Several good candidates have already been characterized 
including ΔCR2 (no transactivation domain), ΔSID (no effect downstream of TGFβ 
signals) and ΔNES (point mutated NES which renders protein constitutively nuclear).      
Despite its unique expression pattern, we have shown that Cited1 is dispensable 
for normal kidney development.  This was of course disappointing, but does not rule out 
the possibility that Cited1 plays other important roles in this context.  Perhaps defects in 
Cited1 null mice could be uncovered using one of the many injury models available for 
study of the kidney.  In fact, preliminary data from our lab suggests that Cited1 is 
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upregulated in the proximal tubule in response to mercury induced tubular injury and 
dedifferentiation.   Furthermore, as discussed above, Cited1 may prove to be an important 
player in the pathogenesis of Wilms’ tumor. 
   
Cited2 and Cited4 in the developing and adult kidney 
Knowing that deletion of Cited1 does not result in defects in kidney development, 
we hypothesized that other members of this gene family could be substituting for Cited1 
in the context of the MM.  We show that Cited2 and Cited4 also have interesting 
expression domains in the developing kidney, though these are distinct from that of 
Cited1.  Cited2 is expressed in the condensed mesenchyme but persists in more 
differentiated epithelial structures, including striking expression in glomeruli.  Cited4, on 
the other hand, is expressed in the UB, most prominently in the tips.  Neither of these 
proteins has been previously investigated in the context of kidney development. 
Owing to their overlapping expression pattern we focused on Cited2 as a 
candidate for functional redundancy with Cited1 in the MM.  To test this hypothesis we 
examined kidney development in Cited2-/- and Cited1-/-/Cited2-/- compound mutant mice.  
These studies required the use of an organ culture system as deletion of Cited2 results in 
embryonic lethality near the onset of kidney development.  In the absence of Cited2 we 
did not observe major perturbation of UB branching or total number of new nephrons 
induced.  While this leads us to conclude that Cited2 is not required in the MM during 
early induction and differentiation events, it does not rule out a role later for Cited2 in the 
developing kidney.  The organ culture system we employed is limited to the study of 
early events as nephron maturation and kidney patterning do not take place in vitro.  The 
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expression domain of Cited2 in glomeruli and the forming papilla suggest that it could 
play a role in both of these processes.  This could be addressed in two ways.  Isolated 
kidney rudiments from Cited2-/- mice could be grown under the kidney capsule of an 
adult host mouse, which allows for maturation and vascularization of the glomerulus as 
well as some cortico-medullary patterning.  Alternatively, Cited2 could be conditionally 
deleted in the MM (and thus in all its derivatives) using our Cited1-CreERT2 animal.  In 
this way we would circumvent the requirement for Cited2 in the heart and placenta and 
have the opportunity to study its function later in the context of nephrogenesis.  In fact, 
our collaborator Sallie Dunwoodie has recently published the creation of a Cited2 
conditional allele which could be used for these studies (Preis et al., 2006).     
Our attempt to generate Cited1-/- / Cited2 -/- double mutant mice revealed that in 
the absence of both of these factors the embryonic lethality observed in Cited2 null mice 
is hastened.  In our studies (totaling 14 litters) only four double null embryos survived 
until E12 (the time of kidney dissection for organ culture), compared just one Cited2 null 
mouse which did not survive.  Deletion of both genes likely exacerbates cardiac defects 
observed in Cited2-/- mice, as Cited1 is also expressed in the developing heart (Fig 15D; 
(Dunwoodie et al., 1998).  In those embryos from which we were able to culture kidneys 
(2 total) we saw a reduction in UB branching and induction of new nephronic epithelia, 
though the overall processes of branching and induction do seem to be intact.  We were 
not, however, able to recover a sufficient quantity of double null kidneys to demonstrate 
statistical significance or examine this possible defect in detail.  This is, again, an 
excellent application for conditional targeting.  By crossing the Cited1-CreERT2 transgene 
(on a Cited1 null background) to the conditional Cited2 allele, we could create double 
 133
mutants in which Cited2 is deleted only in the condensed MM.  By temporally regulating 
control of gene deletion in this system we would hopefully be able to avoid early, lethal 
defects in the heart which may be caused by expression of the transgene, (and subsequent 
deletion of Cited2), in that tissue. 
Cited4 is also expressed in the developing kidney but in a pattern completely 
distinct from Cited1 and Cited2.  It is localized exclusively to the UB, and is expressed 
most prominently in the tips.  This expression pattern is reminiscent of the receptor 
tyrosine kinase Ret, which is required for UB growth in response to Gdnf.  Furthermore, 
both Wnt9b and Wnt11 are expressed in this domain, raising the possibility that Cited4 
modulates transcriptional responses downstream in this pathway (based on the ability of 
Cited1 to do so).  Furthermore, Cited4 is upregulated in cells within the stalk of the UB at 
later stages of kidney development.  It is at this time that UB is elongating and growing 
towards the medulla en route to forming the collecting system.  This presumably requires 
programs which drive proliferation within stalk cells.  Given its expression in tip cells, 
which are highly proliferative, it is possible that Cited4 acts to regulate cell division in 
the UB.  If this is the case, its function is not required in vivo, as we have shown that 
deletion of Cited4 does not perturb UB branching or growth and results in adult mice 
with morphologically normal kidneys.   
Unlike Cited1, Cited2 and Cited4 are both expressed in the adult kidney.  Cited2 
is most prominently expressed in the papilla, and appears to be present in all cell types 
there.  Cited4 expression is restricted to the collecting duct, which along with interstitial 
cells and loops of Henle makes up much of the papilla.  These domains are quite 
intriguing as the papilla is know to be highly hypoxic and the ability of Cited2 and Cited4 
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to regulate hypoxic signaling is well documented (Bhattacharya et al., 1999; 
Bhattacharya and Ratcliffe, 2003; Fox et al., 2004; Freedman et al., 2003).  This raises 
questions about the role of these factors in development and maintenance of cells within 
the papilla through modulation of the hypoxic environment.  In terms of Cited2, this is 
again an excellent opportunity for conditional gene deletion to study its role in papillary 
development, as the strategies we have employed thus far do not allow us to examine the 
effects of Cited2 deletion at later stages of development.  These genes may also serve an 
important role in papillary function in the adult, which can only be uncovered by 
experimentally stressing the system and investigating the physiological consequences of 
Cited2/4 deletion in this context.  Either way, the interesting expression pattern of these 
proteins in the adult offers an additional opportunity to address the function of Cited 
family genes in vivo.   
 
Regulation of cell-ECM interactions by Cited1 
As an adjunct to the work I have done in vivo, I have also used cell culture 
systems to address the function of Cited1.  Initial attempts at this highlighted the well 
known difficulties associated with working with MM derived cell lines.  The data I 
generated using a rat MM cell line were inconsistent and difficult to reproduce and left us 
in search of another platform on which to address the function of Cited1.  Using MCF7 
cells, a ductal breast cancer line which express high levels of Cited1 endogenously, we 
modulated Cited1 protein levels using siRNA.  This approach uncovered a role for Cited1 
in regulation of cell-ECM interactions as knockdown of Cited1 compromised the ability 
of MCF7 cells to migrate through a matrigel matrix.  This effect was associated with a 
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defect in the ability of these cells to adhere to selective components of the ECM 
including Laminin I and Type 1 collagen and a failure of characteristic actin organization 
during attachment.  From a kidney development standpoint this is interesting because the 
way cells within the cap mesenchyme interact with the environment in which they find 
themselves almost certainly determines their ability to move around the UB tip and form 
early epithelial structures.  
It is unclear by what mechanism Cited1 exerts its effect on cell migration and 
adhesion, but we have ruled out changes in cell surface expression of β1, α1, or α6 
integrin as well as impaired phosphorylation of FAK.  There are several issues that can be 
addressed in an attempt to understand the function of Cited1 in this setting.  The first step 
in this process would be to show that mouse Cited1 expressed in MCF7Cited1K/D cells 
could elude siRNA and rescue defects in cell adhesion.  I have developed several of the 
tools needed for this system and work in the lab is ongoing.   
Provided we could rescue this phenotype with transfected mCited1, we could test 
different parameters of its function in this system.  For instance, one issue is whether 
Cited1 mediates MCF7 adhesion through transcriptional or a non-transcriptional 
mechanisms.  The fact that we so often detect Cited1 predominantly in the cytoplasm 
raises the possibility that it may have non-nuclear functions.  These types of experiments 
would be best accomplished using a system in which we could regulate the trafficking of 
Cited1 to the nucleus through fusion to a steroid receptor.  In this way we could express 
full length Cited1 and deletion mutants and assay for their ability to rescue the adhesion 
defect and the ask questions about the role of subcellular localization in this process.   
Having this information would allow us to focus on a potential mechanism en route to 
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understanding how Cited1 regulates adhesion.  For instance, if we determined that 
cytoplasmic localization was necessary for this action we could further interrogate the 
integrin signaling pathway downstream of FAK by looking at activation of other 
important players in cell adhesion and migration, such as the Rho and Rac family of 
small GTPases.  If we saw that nuclear translocation and transcriptional activity were 
required to rescue the defect, we could use microarray or ChIP on chip to look for Cited1 
target genes which regulate cell adhesion.  Interesting findings from these studies could 
then be applied to in vivo investigation in the developing kidney.   
 
Cited1-CreERT2 mice and patterns of cap mesenchyme differentiation 
Despite the fact that Cited1 is not required for normal nephrogenesis, we saw its 
expression domain as a unique opportunity to fate map a distinct population of renal 
progenitor cells.  To do this we utilized a BAC strategy to create a transgenic mouse 
which expresses an inducible form of Cre recombinase under the control of Cited1 
promoter elements.  By crossing this mouse with a conditional reporter line, such as 
R26RLZ, we can acutely tag Cited1 expressing cells in the cap mesenchyme.  Because the 
‘tag’ in this system occurs at the genomic level, all progeny of cells that were tagged in 
the cap will express the reporter.  In this way we can ask question about the fate and 
differentiation patterns of these progenitor cells.   
 My work has shown that cells within the cap mesenchyme are capable of giving 
rise to specialized epithelial cells in all segments of the mature nephron.  Furthermore, 
nephrons which arise prior to E18 can become so called ‘deep’ nephrons, whose distal 
elements extend all the way to the papilla.  By contrast, nephrons which are specified 
 137
after E18 only occupy the superficial compartment, with their deepest elements reaching 
only the into the medulla.  This distinct pattern of timing of nephron differentiation has 
not been previously shown.  
 We have also used this tool to address the question of cap mesenchyme 
repopulation.  Because successive generations of new nephrons are induced throughout 
kidney development, there must be a mechanism that provides a continual pool of 
progenitor cells at each UB tip.  This process is not well understood.  The two models 
most often discussed are 1) new cap mesenchyme is recruited from surrounding cell 
populations, such as the stroma or 2) the cap mesenchyme has programs which hold cells 
in an undifferentiated state and allow for their self-renewal.  Using Cited1-CreERT2 mice 
in our lineage tracing system, we have shown that much of the cap mesenchyme remains 
labeled more that 6 days after tamoxifen administration, this despite the fact that 3 to 4 
generations of nephrons have arisen from the cap since injection.   If new progenitor cells 
were migrating in from outside the cap structure we would expect that labeled cells in the 
cap would be exhausted by formation of primitive nephrons and progressively replaced 
by unlabeled cells.  Instead we see that nearly all cap cells are labeled, indicating that 
they are progeny of the cells originally tagged.  This phenomena has been suspected, but 
not previously shown.  Importantly, a recent paper has demonstrated that the transcription 
factor Six2 is required to oppose MM differentiation and promote renewal of the cap 
mesenchyme (Self et al., 2006).  In the absence of Six2, ectopic renal vesicles form dorsal 
to the UB, and there is a progressive loss of condensed mesenchyme.  Combined with our 
data, these results strongly support a model in which renal progenitor cells are capable of 
self-renewal.  
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 As detailed above, we envision the Cited1-CreERT2 transgenic mouse as a broadly 
applicable tool for the study of kidney development.  Though many experiments using 
this line can be imagined, I would like to highlight two that are of particular interest.   
 The possibility that Cited1 regulates cell adhesion and migration brings to light 
how little we know about this process in the context of the cap mesenchyme.  For 
instance, we do not understand the dynamics of cell movement out of the cap 
mesenchyme en route to forming the PTA and RV or how these cells change their ability 
to interact with one another and the ECM.  Such issues have been exquisitely addressed 
in the UB using time-lapse live cell imaging in cultured kidney explants (Shakya et al., 
2005).  In these studies the UB is fluorescently labeled allowing for detailed analysis of 
how the UB grows and branches.  By crossing the Cited1-CreERT2  mouse with a 
fluorescent conditional reporter, such as R26RYFP, we can ask similar questions about the 
cap mesenchyme.  Though not shown here, we have demonstrated efficient 
recombination using soluble tamoxifen in kidneys cultured from Cited1-CreERT2/R26RLZ 
mice.  Using this system we could image real-time events of renal progenitor cell 
differentiation including early movements and fusion with the UB.  Results of these 
studies could then be extended to investigate factors important for these processes, both 
in organ culture through the addition of transgenes or soluble growth factors, and in vivo 
using this platform for conditional gene targeting.   
 Another important experiment which comes to mind is the question of cell fate 
specification within cap mesenchyme cells.  We have shown that when you label a large 
number of these cells, lineage is observable in all segments of the mature nephron.  This 
does not address, however, the potential of an individual cell within the cap mesenchyme.  
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For instance is cell fate pre-determined at this early stage?  Does a given cap cell which 
enters the PTA give rise to say, only podocytes, or can it produce cells in multiple parts 
of the mature nephron?  Furthermore, is there a subset of cells within the cap whose only 
job is to self renew, or are all cap cells capable of this and positional cues determine 
differentiation state?  To address this question properly, we would need to devise a way 
to label a single cell in each cap and then follow its lineage throughout development.  A 
first approach to this would be to identify a dose of tamoxifen which was sufficiently low 
to tag only one cell per cap.  This could be confirmed acutely, by looking at labeled cells 
shortly after injection.  For instance, if a single cell has been labeled and divided once we 
would expect to see these two cells in close proximity to one another, whereas if many 
cells in the cap had been labeled we would see clusters of cells within the MM. This early 
lineage could be confirmed by co-administering BrdU which would be retained in 
daughters of originally labeled cap cells.  Once this dose has been established we could 
repeat our long term lineage studies to ask questions about the potential of individual cap 
cells.   This could also be carried out in organ culture by using R26RYFP mice and live cell 
imaging.  After determining an appropriate dose of soluble tamoxifen to label single cells, 
we could track the lineage of these cell in real-time.  This method has limitations 
however, as epithelial structures formed in these cultured kidneys do not undergo later 
patterning events.   
 If we could not identify a dose of tamoxifen which has this effect, an alternative 
approach would be to utilize the LaacZ system of clonal analysis (Bonnerot and Nicolas, 
1993; Nicolas et al., 1996).  In this system a reporter construct which contains a 
duplication of the LacZ ORF is inserted downstream of an appropriate promoter, and 
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expressed as a transgene in mice. This duplication results in a non-functional LacZ 
transcript.  In a very small percentage of cells, however, this duplication is corrected by 
an intergenic recombination event, restoring proper LacZ expression.  The likelihood that 
this correction would happen in more than one cells in a given population is extremely 
low.  Using this method, we could administer a normal dose of tamoxifen yet only label 
single cells within the cap.   The progeny of these cells could then be examined in the 
embryo and the adult, addressing questions of differentiation patterns and fate potential 
of clonal derivatives of individual progenitor cells. 
 
Concluding remarks 
The studies presented here demonstrate that the Cited family of transcriptional co-
factors are dynamically expressed in the developing kidney, but are not required for 
nephrogenesis.  While we do not yet understand the function of these proteins in this 
setting, this work has opened other avenues worthy of investigation which should shed 
light broader aspects of kidney development.  Most notably, we have described the 
generation of a Cited1-CreERT2 transgenic animal which has allowed us to uncover 
previously unknown patterns of cell fate in the developing and adult kidney.  Aside from 
these studies, the spatial restriction and inducible nature of this transgene makes it a 
novel, powerful tool which can be widely applied in the field of kidney development to 
study gene function in the cap mesenchyme.      
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